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ABSTRACT 
 
 
Studies have discovered higher frequencies of single nucleotide 
polymorphisms (SNPs) in different mitochondrial genes are associated with 
subnormozoospermia. However, the frequencies of SNPs in ND1 and ND2 
are not unknown. The present research was aimed to determine the 
frequencies of SNPs in ND1 and ND2 genes of the mitochondrial genome in 
fertile and subfertile men and whether changes in codon usage was 
associated with fertility phenotypes. Total genomic DNA from 157 semen 
samples was extracted using the proteinase K/SDS digestion procedure, 
followed by phenol/chloroform purification and ethanol precipitation. ND1 
and ND2 genes were amplified respectively from 80 and 92 DNA samples 
from different fertility groups. Each PCR product was sequenced to identify 
mutations. Codon change resulting from a nucleotide substitution was 
determined by comparison with a reference mtDNA sequence obtained from 
the NCBI database. The frequency of codon usage in the reference mtDNA 
was determined by the computer program MEGA version 2.1. Eleven 
synonymous nucleotide substitutions and two non-synonymous substitutions 
were found in this study. Four SNPs were previously characterized; all 
SNPs were homoplasmic. None of the SNPs were likely to affect the 
function of the proteins on the basis of the hydrophobicity plots or 
secondary structure predictions. Sixty two percent of synonymous mutations 
were found to change from a high to a low relative codon usage values; 37% 
of synonymous mutations changed from a low to a high relative usage 
value. Chi-square (χ2) test (χ2= 0.067 with 1 d.f.) showed that there was no 
significant difference at the 5% level between these changes. Thus, change 
in codon usage was not related to semen quality in men. Further, there were 
no statistically significant differences in the observed frequencies of SNPs 
of fertile and subfertile men. However, the sample size was small and this 
study was only focused on a single NZ Caucasian population. Further study 
including larger and more diverse population samples may provide further 
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insight into the functional importance of codon usage and its relevance to 
fertility status in men.  
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INTRODUCTION 
 
 
 
1.1 THE MITOCHONDRION 
 
  
The mitochondrion is the “power house of a cell” and was first described 
by Altman in 1890 (cited in Cummins, 2001). This thread-like organelle 
is responsible for cellular metabolism and programmed cell death 
(Grossman, 1995; Cummins, 2001). Mitochondria contain their own 
DNA. Mutations in the mitochondrial genome play a major role in some 
human genetic diseases (Wallace et al., 1999; DiMauro and Schon, 2001; 
Wallace, 2005).  
 
 
 
 
Fig 1.1 The human mitochondrion. A mitochondrion under electron 
microscopy (left) and schematic diagram of a surface cut mitochondrion 
with its internal structure (right).Taken from Snustad and Simmons 
(2000). 
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1.1.1. STRUCTURE OF MITOCHONDRIA 
 
Mitochondria are found in the cytoplasm of eukaryotic cells and are 
therefore completely separated from the nucleus and nuclear DNA. With 
the exception of red blood cells, all eukaryotic cells contain many 
mitochondria. These semiautonomous organelles vary greatly in size and 
shape (Darley-Usmar et al., 1994). The structures of mitochondria are 
highly conserved in different organisms. Each mitochondrion has an 
outer and an inner membrane (Figure 1.1). The outer membrane contains 
the original host membrane and forms a permeability barrier to cations 
(Cummins et al., 1998). The inner membrane consists of finger-like 
projections called cristae. Cristae are impermeable (Cummins et al., 
1998) and contain essential enzymes for metabolic functions such as ATP 
synthesis and cell respiration. ATP is produced by oxidative 
phosphorylation (OXPHOS).  
 
 
1.1.2. FUNCTION OF MITOCHONDRIA 
 
The main function of mitochondria is oxidative phosphorylation. This 
process is carried out by an electron transport chain, which is mediated by 
different protein complexes. The five complexes are nicotinamide 
adenine dinucleotide coenzyme Q reductase (NADH-CoQ reductase) 
(complex I), succinate CoQ reductase (complex II), ubiquinol 
cytochrome b reductase (complex III), cytochrome c oxidase (complex 
IV) and ATP synthase (complex V). Figure 1.2 is a schematic diagram of 
the OXPHOS pathway in a mitochondrion. Complex I uses the energy in 
NADH to pump protons into the inter-membrane space of the 
mitochondrion. Complex I receives electrons from succinate. These 
electrons are delivered to complex III by coenzyme Q. Complex III 
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delivers electrons to complex IV and reduces oxygen atoms inside the 
matrix to H2O. A proton motive force is then generated in the inter-
membrane space by coupling electron transport to protein translocation at  
 
 
 
Fig. 1.2. Schematic representation of oxidative phosphorylation. The 
enzymes of the mitochondrial inner membrane involved in OXPHOS and 
protons are translocated across the membrane to generate ATP. Diagram 
was taken from Saraste (1999).  
 
 
 
complex I, II, and IV (Moore et al., 2000; Wallace, 2001; Wallace, 2005; 
Schắfer et al., 2006). The enzyme ATP synthase generates ATP when 
protons are transported down their concentration gradient into the matrix. 
Complex I, III and IV are partially encoded by mtDNA and crucial for 
generating the proton motive force (Moore et al., 2000). OXPHOS 
generates reactive oxygen species (ROS), an endogenous toxin as a by-
product (Reha and Robinson, 2001).  
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ROS are generated in the form of OH•, O2_, and H2O2  by reduction of 
oxygen. ROS are highly mutagenic and/or carcinogenic (Cummins, 
2001). In the human body each mitochondrion produces 1 × 107 ROS per 
day. Since mitochondria occupy up to 25% of the total cytosol, the cell is 
very susceptible to oxidative damage (Cummins, 2001). ROS can damage 
the mitochondrial and cellular proteins, lipids, nucleic acids, mtDNA, and 
interrupt energy production (Attardi et al., 1988; Wallace et al., 1999; 
Wallace 2005).  
 
Excessive production of ROS may cause programmed cell death 
(apoptosis), which is another function of mitochondria. Apoptotic 
cascade is generated by the activation of mitochondrial permeability 
transition pore (mtPTP) (Wallace, 2001). Cytochrome c is released 
(Green and Reed, 1998). The release of cytochrome c and the latent form 
of specialized proteases, caspases, promote programmed cell death by 
activating the cytosolic protein degradation pathway and destroying the 
cytoplasm (Wallace et al., 1999). This interrelated system involved in 
apoptosis is assembled from roughly 1500 genes distributed in the 
nuclear and mitochondrial genomes (Wallace, 2005). 
 
1.1.3. HUMAN MITOCHONDRIAL GENOME 
 
The human mitochondrial genome (mtDNA) is 16,569 base pairs (bp) of 
nucleotides in length (Anderson et al., 1981). The genome is a double-
stranded, covalently closed circular DNA molecule with little redundancy 
and rare forms of telomere like terminations (Cummins, 2001). The 
mtDNA is located within the mitochondrial matrix. The mitochondrial 
genome encodes 37 genes including 2 ribosomal RNAs (rRNAs), 22 
transfer RNAs (tRNAs) and 12 polypeptides (Wallace et al., 1999; 
Shanske et al., 2001; Wallace, 2005). The 12 polypeptides include seven 
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subunits of NADH dehydrogenase (ND1, ND2, ND3, ND4, ND4L, ND5 
and ND6) that make up complex I, a cytochrome b in complex III, three 
complexes of cytochrome c oxidase in complex I, II,  III and complex IV, 
and two ATP subunits, ATPase6 and ATPase8, in complex V (Anderson 
et al., 1981) (Figure. 1.3).  MtDNA has two strands, a guanine rich 
(heavy, H) strand and a cytosine rich (light, L) strand (Wallace, 1992). 
The heavy strand contains 12 of the 13 polypeptide encoding genes, 14 of 
the 22 tRNA encoding genes and both rRNA encoding genes (Wallace, 
1992). Introns are absent in mtDNA and all of the coding sequence are 
contiguous (Anderson et al., 1981; Wallace, 1992).  
 
 
 
Fig.1.3. Structure of a human mitochondrial genome. Modified from 
Wallace et al. (1999). 
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The non-coding segment of mtDNA is the displacement loop (D loop), a 
region of 1121 bp that contains the origin of replication of the H strand 
(OH), and the promoters for L and H stands (PL and PH) (Wallace, 1999). 
The mtDNA is replicated from two origins. 
 
DNA replication is initiated at OH using an RNA primer generated from 
the L strand transcript. H strand synthesis proceeds two-third of the way 
around the mtDNA, displacing the parental H strand until it reaches the L 
stand origin (OL), situated in the cluster of five tRNA genes (Holt, 1994). 
The L strand synthesis starts at OL and further proceeds back along the H 
strand (Wallace, 1992; Holt, 1994). MtDNA replication is bidirectional. 
Transcription of mtDNA is initiated from two promoters in the D loop, PL 
and PH. Most of genes are transcribed from PH, which reads anti- 
clockwise and from PL transcription which starts clockwise (Wallace, 
1992).  
 
 
1.1.4. MITOCHONDRIAL GENETICS 
 
The location of mtDNA and the high copy number contribute a number 
of unique features to mitochondria (Wallace, 1999). MtDNA differs from 
nuclear DNA as it is maternally inherited; it has a higher mutation rate 
than nuclear DNA; it demonstrates replicative segregation and threshold 
expression, and is more susceptible to mutation. 
 
Maternal inheritance is a unique feature of the mitochondrial genome. 
The mammalian egg contains about 100,000 molecules of mtDNA, while 
sperm cells contain 100-150 mtDNA (Chen et al., 1995). Sperm 
mitochondria enter into the egg and are discarded by the egg during 
fertilization (Cummins et al., 1997; 1999; Cummins, 2001; DiMauro et 
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al., 2001), although low level of paternally transmitted mtDNA 
representing ~104 of total mtDNA have been detected in mice (Wallace, 
1994).  
 
The high mutation rates observed in mtDNA is a result of the lack of 
efficient DNA repair mechanisms (Bogenhagen, 1999). Further, mtDNA 
is not bound to histone (Cummins, 2001). Thus, it is not protected from 
oxidative damage due to the highly toxic ROS, which are by-products of 
OXPHOS. MtDNA damage can be expected to have an impact on cell 
function as the probability of damaging coding sequences is higher. If 
damage accumulates, cellular function will be impaired because 
mitochondria are deficient in a nucleotide-excision repair (NER) and 
mismatch repair (MMR) system. This limitation of a repair system would 
partly explain the higher rate of mutations in mitochondria (Bogenhagen, 
1999; Copeland et al., 2002). The mutation rate in mtDNA is 10 times 
higher than in nuclear DNA (Cummins, 2001).   
 
The third distinctive feature of mitochondria is the replicative segregation 
of mtDNA during meiosis and mitosis (Wallace, 1999; Shanske et al., 
2001; Wallace, 2005). Each cell contains hundreds of mitochondria and 
each mitochondrion contains 10-100 copies of mtDNA. Normally all 
mtDNA in a cell are identical (homoplasmy) (DiMauro et al., 2003). 
During cell division the mitochondria and their genomes are randomly 
distributed to the daughter cells by a process called replicative 
segregation (Wallace, 1999). The higher rate of mutation in mtDNA 
creates a mixture of mutant and wild type DNA molecules, which is 
known as heteroplasmy (DiMauro et al., 2003). Not all but most of the 
pathogenic mutations are heteroplasmic (Shanske et al., 2001; DiMauro 
et al., 2003).  
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A minimal number of mutant mtDNAs has to be present within a tissue 
before oxidative dysfunction occurs. This is called the threshold effect 
(DiMauro, 2003). This threshold varies for different types of mtDNA 
mutations. When the threshold level is exceeded, changes occur in the 
phenotype (Shanske et al., 2001). Organs such as, heart, brain etc. with a 
high ATP demand will have the lowest regenerative capacity (Wallace et 
al., 1999; Wallace, 2005).  
 
The mitochondrial mutation rate is 10-20 times higher than nuclear DNA 
(Wallace, 1992). Since the mitochondrial genome does not contain 
introns and non-coding sequences, any mutation occurring in mtDNA 
would affect the coding regions. Thus, a variety of neutral and mildly 
deleterious mutations are found in human populations.  
 
1.2. MITOCHONDRIAL DNA MUTATIONS AND 
DISEASE 
 
Disease caused by mitochondrial dysfunction can be due to mutations in 
mtDNA. The first oxidative disorders were described by Luft et al. in 
1958 (cited in Haushmand, 2003). The term mitochondrial disorder refers 
mainly to the disorders with abnormal morphological aspects of 
mitochondria in muscle (DiMauro et al., 2000). In 1988, the first 
pathogenic mutations associated with myopathy were discovered by Holt, 
who found large scale detections in mitochondria (cited in Haushmand, 
2003). In the same year, Wallace et al., reported a point mutation in the 
ND6 gene associated with LHON (Leber’s hereditary optic neuropathy). 
Houshmand (2003) stated that, in 1990, two new mutations were 
discovered, A8344G in tRNAlys (Shoffner et al., 1990) and A3243G in 
tRNAleu (UUR) gene in MELAS syndrome (Goto et al., 1990). To date 
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more than 100 pathogenic mutations have been found to be associated 
with human diseases (DiMauro et al., 2000). MtDNA mutations cause 
defects in brain, heart, muscle vision and hearing, and are also involved 
in other abnormal cellular states such as cancer (Jakupciak et al., 2005), 
diabetes mellitus (Thomas et al., 1996) and infertility (Ruiz-Pesini et al., 
2000; Holyoake et al., 2001; Thangaraj et al., 2003).  
 
Three different types of mtDNA mutations have so far been reported to 
be involved with diseases. They are single nucleotide deletions in tRNA 
and rRNA genes and in protein-coding gene (Shanske et al., 2001; 
DiMauro et al., 2001; 2003). These mtDNA mutations will affect protein 
synthesis in the mitochondria. Although in most cases, single nucleotide 
deletions in mitochondria are sporadic events (DiMauro et al., 2001; 
Shanske et al., 2001).  
 
The most commonly observed point mutation is A8344G, located in 
MERRF disease in tRNAlys gene. These mutations are heteroplasmic and 
vary widely between different individuals and different tissues of the 
same individual (Wallace, 1992). Many pathogenic mutations have been 
found in the tRNAleu gene. High levels of A3243G mutations have been 
found in muscles and ragged red fibers (Wallace et al., 1999). It was also 
associated with MELAS and KSS. Two other mutations (T3271C and 
T3291C) are reported to be associated with MELAS (Goto et al., 1994). 
T7512C, T9957C and T8357C mutations are also found with 
MERRF/MELAS. Some rRNA mutations are also associated with 
deafness, complex neurology and diabetes mellitus type II (DiMauro et 
al., 2003; Haushmand, 2003). These mutants are A1155G, G1606A and 
T3200C. 
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The first mitochondrial point mutation discovered in a protein coding 
gene was associated with a maternally inherited disease called LHON 
(Wallace, 1988). Four main mutations in the complex I gene (ND gene); 
G11778A in ND4, G3460A in ND1, T14484C and G14459A in ND6 are 
associated with LHON (DiMauro et al., 2003). Recently T4216C in the 
ND1 gene was reported to be associated with LHON (www.mitomap.org, 
as for 18th may, 2006). LHON patients normally lose their eye sight 
rapidly during adolescent (Leonard et al., 2000). Houshmand (2003) 
reported that at least fifteen other LHON mutations were proposed by 
Howell et al. (1995) and Brown et al. (1995). G11778A, G3460A and 
T14484C cause reduction in NADH respiratory substrates and also 
partially reduce complex I activity (Wallace, 1999). Another T8993C 
heteroplasmic mutation in the ATPase6 gene in mtDNA was found to be 
associated with maternally inherited NARP syndrome (Shanske et al., 
2001; Wallace, 2005). 
 
1.2.1. THE ASSOCIATION OF MITOCHONDRIAL DNA 
HAPLOGROUPS WITH DISEASE 
 
MtDNA haplogroups analysis is one of the tools used to study human 
pathologies (Torroni et al., 1996; Ruiz-Pesini et al., 2000). MtDNA 
haplogroups were initially based on information provided by RFLPs and 
the hypervariable segments of the control region (Finnila et al., 2001) but 
are now commonly defined by whole mtDNA sequence analyses.  
 
Recent studies have shown that mtDNA haplogroups play an important 
role in disease expression. Haplogroup J was associated with LHON 
(Torroni et al., 1996; Wallace et al., 1999; Wallace 2005). Wallace 
(1999) showed that 47 of LHON patients of European descent contain 
three primary mutations:  MTND4*LHON11778A, MTND1*LHON3460 
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and MT*ND6LHON14484C. The association between MTND6*14484C 
and haplogroup J was striking. Haplogroup J contains only 9% of 
European population and 37% LHON patients showed 
MTND4*LHON11778A mutation, while 80% were with 
MT*ND6LHON14484C. Association of haplogroup J with the LHON 
mutation at nt 9438 in COX III was also observed in Caucasian 
populations. The J haplogroup with mild MTND1*4216C variant might 
be also associated with LHON (Wallace, 1999; 2005).  
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1.3. HUMAN INFERTILITY  
 
1.3.1 GENERAL ASPECTS OF HUMAN INFERTILITY 
 
Reproduction is a natural process. Infertility is a reproductive health 
problem that affects many couples in the human population. About 13-
18% of couples suffer from it, and one half of all cases can be traced to 
either partner (Seshagiri, 2001). Infertility is the inability to conceive 
after a period of 12 months of intercourse without using any 
contraception or inability to carry pregnancies to live birth (Cummins et 
al., 1994).  
 
 
1.3.2. HUMAN MALE INFERTILITY 
 
Male infertility is much more difficult to describe than female infertility 
(Cummins, 1994). Recent evidence suggests that male infertility has a 
genetic cause (Affara, 2001; Holyoake et al., 2001; Spiropoulos et al., 
2002). Around 20-25% of infertility cases are due to male factors (De 
Krestser et al., 1999).  
 
 
1.3.3. SPERMATOGENESIS 
 
Spermatogenesis is a complex process. This biological process occurs in 
the seminiferous tubules of the testes (Purves et al., 2004). 
Spermatogenesis begins in the male germ cell line, which contains stem 
cells that produce spermatogonia. Repeated mitotic divisions produce 
diploid spermatocytes from spermatogonia (Holstein et al., 2003). Each 
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primary spermatocyte then divides by meiosis to produce secondary 
spermatocytes, which further divide to produce four haploid cells called 
spermatids (Holstein et al., 2003). Spermatids pass through the process of 
spermiogenesis and become free living spermatozoa. Figure 1.4 is a 
diagram showing the human spermatogenesis process.  
  
 
 
Fig 1.4. Human spermatogenesis process. Diagram was taken from 
Snustad and Simmons (2000). 
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1.3.4. HUMAN SPERM CELL STRUCTURE  
 
The human sperm cell consists of three parts: head, midpiece and tail (Fig 
1.5). The head contains a nucleus and has a cap like structure called the 
acrosome. The acrosome enables the sperm cell to penetrate the egg. 
Motility is the purpose of the sperm tail. The midpiece is tightly packed 
with mitochondria. A typical sperm cell contains 20-28 mitochondria (St 
Jones et al., 2001). These mitochondria generate ATP to provide energy 
for sperm to swim (Kao et al., 1998). Defects in the internal structure and 
organization of mitochondria in the midpiece are linked to poor semen 
quality in men (Kao et al., 1998) and low sperm motility (Thangaraj et 
al., 2003). 
 
 
 
 
Fig. 1.5. A typical structure of a sperm cell. Taken from Purves et al. 
(2004). 
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1.3.5. CAUSES OF MALE INFERTILITY 
 
Male infertility may be caused by obstructive lesions, spermatogenic 
failure, sexual dysfunction, endocrine disorder and idiopathic sperm 
dysfunction (Cummins et al., 1994). Approximately 7-15% of infertile 
men suffer from obstructive lesions and have ejaculatory problem. 
Spermatogenic failure disrupts spermatogenesis and its cause is still 
unknown (Namiki, 2000). Mutations in germ line genes may be a cause 
of defective spermatogenesis. Approximately 30% of infertile men tend 
to show defect in spermatogenesis (Cummins et al., 1998). Idiopathic 
sperm dysfunction is related to environmental factors (smoking, drugs, 
heavy metals, etc.). Many cases of idiopathic infertility have a genetic or 
molecular basis (Seshagiri, 2001). 
 
 
1.3.6. GENETIC BASIS OF MALE INFERTILITY 
 
Genetic disorders involved in male infertility can be due to chromosomal 
abnormalities, autosomal gene defect or Y chromosome mutation.  
 
The 47, XXY karyotype variant of Klinefelter’s syndrome, is the most 
common chromosomal disorder associated with male infertility (Singh et 
al., 2006). Eleven percent of azoospermic and 0.7% of oligozoospermic 
men tend to have this condition (Bhasin et al., 2000). Autosomal 
abnormalities in men may cause congenital bilateral absence of vas 
defense (CBVAD), which is associated with the cystic fibrosis 
transmembrane conducted regulator gene. This is responsible for 1-2% of 
infertility in men (De Krestser et al., 1999). Four percent of infertile men 
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tend to show sex-chromosomal abnormalities, while 1% shows autosomal 
abnormalities (Singh et al., 2006). 
 
The Y chromosome is mainly responsible for male infertility. Y-linked 
mutations have most effects on spermatogenesis (Hargreave et al., 2000; 
Singh et al., 2006). Y-chromosome microdeletions were detected in men 
with suboptimal semen parameters (7.4%) (Erasmuson et al., 2003). 
Microdeletions in the AZF factor, located in the long arm of Y 
chromosome are associated with male infertility (Vogt et al., 1996). The 
AZF factor consists of four regions: AZFa, AZFb, AZFc and AZFd 
(Brinton-Jones et al., 2000) (Fig 1.6). Three genes (DAZ, RBM and 
DFFRY) are also located in these regions. 
 
 
Fig 1.6. Schematic representation of the human Y chromosome 
containing AZF region. Modified from Brinton-Jones et al. (2000). 
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The DAZ (Deleted in azoospermia) gene located in the AZFc region of 
the Y chromosome and is found to be deleted in 10-15% oligozoospermic 
and azoospermic men (Moore et al., 2000). The RBM (RNA binding 
motif) gene is in the AZFb region (Moore et al., 2000). Deletions of this 
region are found in oligozoospermic and azoospermic men. Similarly, 
DFFRY (Drosophila fat facet related Y) gene located in the AZFa region 
is associated with male infertility. Another azoospermic factor AZFd is 
proposed by Kent-First et al. (1999), which is associated with mild 
oligozoospermia or normal sperm count with abnormal sperm 
morphology (Brinton-Jones et al., 2000). 
 
X linked disorder, such as Kaltman’s syndrome is also suggested to be 
associated with male infertility (mutations in a gene on XP22.3) 
(Seshagiri, 2001). Infertile men tend to show higher incidence of 
translocation (Affara, 2001). But this contribution to infertile men has not 
properly understood (Huyanh et al., 2002). However, a CAG repeat at the 
amino terminal domain of the androgen receptor is believed to cause a 
defective spermatogenic disorder, but the role of this CAG repeats is 
controversial (De Krestser et al., 1999; Erasmuson et al., 2003). Men 
with poor semen quality showed similar CAG repeat number to men with 
normal semen quality (21.46 ± 0.30 vs. 20.99 ± 0.28, p = 0.126) 
(Erasmuson et al., 2003). Therefore, higher CAG repeats are not always 
associated with infertility in men. 
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1.3.7. MALE INFERTILITY AND MITOCHONDRIAL 
DYSFUNCTION 
 
Sperm motility is one of the major factors of male infertility (Ruiz-Pesini 
et al., 2000). Sperm movements require large amount of ATP. A defect in 
mitochondrial respiratory function causes a decline in motility and 
infertility (Kao et al., 1998; Ruiz-Pesini et al., 2000). Mutations in the 
mtDNA of a sperm cell can result in either function-less or 
malfunctioning proteins that affect sperm motility (Thangaraj et al., 
2003).  
 
Ruiz-Pesini et al. (2000) showed that asthenozoospermia, not 
oligozoospermia, was associated with mtDNA haplogroups and 
spermatozoa dysfunction. Mitochondrial haplogroup H was more 
abundant in non-asthenozoospermia and haplogroup T was more 
abundant in asthenozoospermia. Three nucleotide positions 7025 (COI), 
10394 (ND3) and 12308 (tRNALeu) were identified in haplogroup H and 
significantly more frequent in samples with high sperm motility. Five 
nucleotide positions 4216 (ND1), 4914 (ND2), 7025 (COI), 13366 (ND5) 
and 13704 (ND5) are identified in T haplogroup. The presence of these 
SNPs is frequently observed in semen samples of poor quality. But 
Thangaraj et al. (2003) established that mitochondrial mutations in sperm 
can cause low sperm motility that is not related to infertility. They 
obtained 8, 13, 5 and 10 SNPs in COI, COII, ATPase8 and ATPase6 
genes, respectively, in the sperm DNA of an oligoasthenozoospermic 
man. These mutations was associated with low motile sperm but was 
fertile.  
 
Spiropoulos et al., (2002), studied the semen sample of a man who was 
inherited with an A3243G mutation in mtDNA. Using a percol 
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fractionation method, these authors separated sperm into five groups. 
They observed that decreased sperm motility was correlated with an 
increase in mutant mtDNA from 42 to 64%.  
 
Semen samples with a high number of multiple mtDNA deletions appear 
to be associated with male infertility (St-John et al., 2001). Kao et al. 
(1995) found 4977 bp deletions in mtDNA in normal semen parameters 
and this showed a negative correlation between base pair deletion and 
sperm motility. But Cummins et al. (1998) repeated this experiment and 
found this deletion in men with normal sperm parameters. He suggested 
that spermatozoa might contain huge number of mutations that can cause 
sperm dysfunction. He also proposed that defective respiration in sperm 
mitochondria will produce ROS and cause cellular damage. Most 
mutations in mtDNA that are associated with asthenozoospermia are 
caused by ROS (St-John et al., 2001). Male infertility is associated with 
oxidative stress and oxidative damage (Cummins et al., 1994; Smith et 
al., 2006). Oxidative stress plays a major role in the etiology of defective 
sperm count (Sharma et al., 1999). Spermatozoa are vulnerable to lipid 
peroxide damage. Production of abnormal levels of ROS alters the 
spermatozoa membrane function, morphology, impaired metabolism, 
motility and fertility (Cummins et al., 1994). Excessive ROS production 
will decrease sperm motility and viability. This will increase midpiece 
sperm defects and acrosome reaction (St-John et al., 2001)  
 
Holyoake et al. (1999) found that severe oligozoospermic men with a 
T8821C point mutation in the ATPase6 gene possess immature 
spermatids. These authors also found a high incidence of nucleotide 
substitutions in the mitochondrial genome which were associated with 
poor semen quality (Holyoake et al., 2001). They showed that 8.4% of 
subnormozoospermic men contain SNPs, while 2.4% normozoospermic 
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men had an SNP. The two most common substitutions occur in nt 9055 
and nt 11719. Eleven percent of men with poor semen quality showed nt 
9055 substitution, but only 1.3% of men with normal fertility had the 
same substitution. Similarly for the nt 11719 substitution, 12% 
subnormozoospermic men are associated this substitution. 
 
     
1.4. GENETIC CODE 
 
1.4.1. GENETIC CODE VARIATION 
 
The genetic code directing translation of mtDNA differs from the 
universal genetic code (Anderson et al., 1981). In the mammals’ mtDNA, 
UGA encodes tryptophan instead of being a termination codon. AUG 
encodes methionine instead of isoleucine and AUG and AGG are 
termination codons, instead of arginine (Wallace, 2005).  
 
In human, eight mitochondrial tRNAs recognize eight codon families 
with four fold degeneracy and 14 recognize the remaining codons (cited 
in Hoaushmand, 2003). The aminoacyl~tRNAs are activated with ATP 
and are the precursors of polypeptide synthesis on ribosomal RNA which 
recognizes the correct mRNA codons (Gardner et al., 1991). This 
facilitates the formation of peptide bonds between new amino acids and 
growing peptide chains. Most amino acids have more than one codon. 
These codons specifying for the same amino acids are called synonymous 
codons. 
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1.4.2. CODON USAGE 
 
An important characteristic of codon usage is that synonymous codons 
are used often with different frequencies (Bulmer, 1991). The factors that 
can influence codon usage are related to nucleotide base compositions 
and genome size. Mutational bias plays a major role in determining 
nucleotide base substitutions (Sharp, 1989). Replication errors, repair 
efficiencies are reflected from mutational bias. Third position transitions 
in a codon are more common and these mutations are usually 
synonymous. 
 
Bulmer (1991) and Akashi (1994) demonstrated that several tRNAs 
recognize groups of synonymous codons. Codon recognized by the most 
abundant amino acids tends to be used preferentially. Among codons, 
those which recognized by the most abundant tRNAs are not as favored 
as the codons that form the natural Watson-crick pairing with tRNA 
anticodon. Strongly expressed genes are corresponding to most abundant 
tRNAs than weakly expressed genes. These biases give rise of two 
models (selective and neutral theory) to explain the preferential use of 
synonymous codons (Duret, 2003). 
 
In humans, roughly 99.8% of DNA sequence variations do not alter the 
primary sequence (Venter et al., 2001). However, there are controversies 
on the functional neutrality of synonymous codons. Not every 
synonymous site is neutral (Chamary et al., 2005). Chamary et al. 
demonstrated that synonymous mutations in mammalian exon can be 
selective and mediated by selecting mRNA stability. They showed the 
presence of cytosine at synonymous sites can be accounted for by 
selection and can affect the efficiency of translation via modification of 
the tertiary structure of mRNA. Knight et al. (2001) showed that codon 
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usage can be surprisingly biased in the nuclear genes of different species. 
They observed that the amino acid lysine has two codons, AAA and 
AAG. These codons were used equally in some organisms like 
Lactobacillud acidophilus, but Sterptomyces venezuelae uses AAA only 
2.2% of the time, whereas Buchneria aphidicola uses it 91%. Similarly, 
Carlini et al. (2003) introduced three different unpreferred codons into 
the Drosophila alcohol dehydrogenase gene (Adh). They observed that 
there is a significant decrease in Adh protein production with those three 
unpreferred codons. 
 
Thus, all recent researches reported that codon preference can influence 
translational efficiency. Most of the experiments so far are based on 
nuclear genes and are not related to human. The general concept may be 
applicable for mitochondrial gene but their origin and genetic code is not 
identical.  
 
1.4.3. IS THERE ANY EFFCT OF SYNONYMOUS 
CODON ON MALE INFERTILITY 
 
Synonymous mutations occur in both nuclear and mitochondrial genes. 
But their effects are difficult to detect. Different cells contain different 
number of mtDNA molecules. Further, different homoplasmic mutations 
can affect translation efficiency and upset the metabolic activity to 
different degrees. The oocyte contains thousands of mtDNA but is 
metabolically inactive. Sperm cells are most active and contain smaller 
number of mitochondria than oocytes (Cummins et al., 2001; Kao et al., 
1998; Ruiz-Pesini et al., 2000). Functional failure of sperm will affect the 
reproductive ability of men. 
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It is evident that mitochondrial mutations are associated with male 
infertility (Kao et al., 1998; Holyoake et al., 1999; Ruiz-Pesini et al., 
2000; Spiropoulos et al., 2002; Thangaraj et al., 2003). Synonymous 
codon usage in nuclear genes has been shown to affect translation 
efficiency (Chamary et al., 2005; Knight et al. 2001). Can synonymous 
mitochondrial mutations affect sperm function?     
 
1.5. HUMAN COMPLEX I  
 
Human complex I consists of seven mitochondrial encoded subunits 
(ND1, ND2, ND3, ND4, ND4L, ND5 and ND6) and at least 36 nuclear 
gene coded proteins (Anderson et al., 1981).The total molecular mass of 
complex I is 900 k Da. This is the largest protein complex of the electron 
transport chain. The proteins of complex I are traditionally divided into 
three groups. They are flavoprotein fraction (FPf), iron protein fraction 
(IPf) and hypophobic fraction (HPf) (Hatefi, 1985). The location of ND6 
is still unknown (Tripeles et al., 2001), but the other six proteins are 
located in the HP fraction of complex I.  ND1 is the terminal acceptor for 
quinone reduction within the membrane part of complex I as it has 
ubiquinone binding property. Complex I deficiency syndrome are also 
related with human diseases that include LHON (Wallace, 1999; 2005), 
MELAS and Parkinson disease, etc. 
 
1.5.1. THE HUMAN ND1 AND ND2 GENES AND THEIR 
GENE PRODUCT 
 
The human mitochondrial ND1 gene is 956 bp long and situated between 
nt 3308 and nt 4263 of the mitochondrial genome. ND2 is 1043 bp long 
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and located beside the ND1 gene. ND1 and ND2 genes encode 316 and 
347 amino acid polypeptides, respectively (www.mitomap.org).  
 
ND1 and ND2 genes are found to be associated with a large number of 
substitutions (Howell, 1996; Thomas et al., 1996; Torroni et al., 1996; 
Macaulay et al., 1999; Rose et al., 2001; Harris et al., 2006). Twenty 
published polymorphism that are listed for the ND1 gene are associated 
with different diseases (www.mitomap.org, as for 18th may, 2006) 
(Appendix 4). These diseases occur due to primary mutations 
(homoplasmic mutations) (e.g.G3460A) or secondary mutations 
(heteroplamic mutations) (e.g. T4216C). Similarly, six published 
polymorphisms are listed for the ND2 in the NCBI database that are 
associated with different diseases (LHON, Alzheimer’s disease or 
Parkinson’s disease) (www.mitomap.org) (Appendix 4).  
 
1.6. AIMS OF THE STUDY 
 
Recent studies have discovered numerous single nucleotide 
polymorphisms (SNPs) in the coding regions of the mitochondrial 
genome (Holyoake, et al. 2001; Brandstatter et al., 2003; DiMauro et al., 
2003; Torroni et al., 2003; Harris et al., 2006). Furthermore, different 
frequencies of SNPs in different mitochondrial genes can be associated 
with subnormozoospermia (Holyoake et al., 2001). However, the 
frequencies of SNPs in ND1 and ND2 are not unknown.  
 
The present research is aimed to 
 
1. Determine the frequencies of SNPs in the ND1 and ND2 genes of 
the mitochondrial genome in fertile and subfertile men, as this 
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region is highly polymorphic and is associated with many diseases 
(Wallace, 1999; 2005).  
2. Test the hypothesis that codon usage is associated with fertility 
phenotypes. Single nucleotide substitutions may be synonymous 
or non-synonymous. Studies on nuclear genes have shown that 
synonymous mutations may affect the efficiency of translation 
(Knight et al. 2001; Chamary et al., 2005). Thus, knowing how a 
single nucleotide substitution will change a codon may provide 
insight into the importance of codon usage and whether codon 
usage can explain the associated phenotype.  In the present study, 
codon changes caused by single nucleotide substitutions will be 
determined and the frequency of usage of the codons will be 
determined by comparison with the reference gene sequence 
obtained from the NCBI database. 
 
Experimental approach include 
1. Isolation of genomic DNA from human semen samples with 
normal and poor semen parameters. 
2. Screening of mutations in the ND1 and ND2 genes in the 
mitochondrial genome using the polymerase chain reaction (PCR) 
and sequencing.  
3. Determining the frequency of the ND1 and ND2 mutations. 
4. Determine whether codons are changed by nucleotide 
substitutions by comparing with a reference mtDNA sequence 
obtained from the NCBI database. 
5. Determine the frequency of usage of these changed codons by 
comparison with the frequency of usage in the reference sequence 
determined by MEGA version 2.1 (Kumar et al., 2001). 
6. Determine whether a relationship exist between fertility status and 
codon usage. 
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MATERIALS AND METHODS 
 
 
 
2.1. MATERIALS  
 
 
All the chemicals used in this study were of molecular grade (Appendix 
2). The water used was autoclaved, deionized and ultra filtered (NANO 
pure ultra pure water system, Barnstead, 10, USA) and referred to as 
ddH2O.  
 
 
2.2. COLLECTION OF SEMEN SAMPLES 
 
 
Semen samples were collected from patients of the New Zealand Centre 
for Reproductive Medicine in Christchurch, NZ. These samples were 
provided to the fertility clinic for routine semen analysis because of 
suspected fertility problem. Semen parameters, such as sperm count and 
sperm motility, were measured and recorded by staff at the NZ Centre for 
Reproductive Medicine. Since a suspected fertility problem may be 
attributed to either partner, many of the samples had normal sperm count 
and motility. All semen samples were stored at -80ºC in 200 µL aliquots 
to reduce DNA degradation by repeated freezing and thawing. 
 
Based on the semen parameters, the samples were classified into seven 
groups according to the World Health Organization (WHO) guideline 
from 1999 tabulated in 2.1.  
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Table: 2.1 Classification of Semen Quality based on WHO (1999).  
 
Samples used in this study Classification SpermCount 
(millions/mL)
Motility 
(%)  Total extracted 
Genomic DNA 
  ND1   ND2 
Normozoospermic >20 >50 75 40 46 
Asthenozoospermic > 20 < 50 43 28 28 
Oligozoospermic 5 – 20 >50 10 5 6 
Oligoasthenozoospermic 5 – 20 < 50 11 3 5 
Severely 
Oligozoospermic 
0 – 5 >50 6 2 3 
Severely 
Oligoasthenozoospermic 
0 – 5 >50 5 1 2 
Azoospermic 0 0 3 1 2 
Total   157 80 92 
 
 
 
2.3. DNA PREPARATION FROM SEMEN SAMPLES 
 
2.3.1. DNA EXTRACTION  
 
157 genomic DNA was extracted from semen samples using a standard 
phenol/chloroform method Kao et al. (1995). Semen samples 
(approximately 200 µL) were thawed on ice. To separate spermatozoa 
from seminal plasma centrifugation was carried out at 4500 × g for 10 
min at 4oC in an Eppendorf bench centrifuge. The supernatant was 
discarded. Then the pellet was resuspended in 100 µL of lysis 
mix/extraction buffer (0.1 M Tris-HCl ( pH 8.0), 0.1 M NaCl, 0.5 M 
EDTA (pH8.0), 1% (w/s) SDS, 10 mM dithiothreitol and 100 µg/ml 
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proteinase K) by gently flicking the tube. Samples were then incubated at 
50oC for 16-24 h. Proteins were extracted by adding an equal volume of 
phenol saturated TE8 (pH 8) buffer [10 mM Tris-HCL (pH 8), 1 mM 
EDTA]. Samples were gently mixed by inverting the tubes. To separate 
the aqueous and organic phases the solution was centrifuged at 2400 × g 
for 5 min at room temperature. The aqueous phase was transferred to a 
new tube using a large bore glass pipette. The remaining interphase and 
organic layer were back extracted with an equal volume (100 µL) of TE 
(pH 8.0) to remove residual DNA. Both aqueous phase were combined 
and extracted with equal volume of phenol: chloroform: isoamylalcohol 
(25:24:1). Then the aqueous phase was transferred to another tube and 
extracted with chloroform: isoamylalcohol (24:1). The final aqueous 
phase was transferred to a fresh tube and DNA was precipitated out by 
adding 0.1 volume of 3 M sodium acetate (pH 7) and two volumes of  
cold absolute ethanol (stored at -20oC). DNA was pelleted by 
centrifugation at 13,800 × g at 4oC for 20 min. The DNA pellet was 
washed in 500 µL of cold 70% alcohol. Then, the pellet was air dried for 
10-15 min, resuspended in 50 µL TE8 and stored at 4oC.  
 
 
2.3.2. VISUALIZATION OF EXTRACTED DNA 
 
The presence of DNA was checked by agarose gel electrophoresis. Three 
µL of the extracted DNA and 3 µL of orange G (30% glycerol and 0.35% 
orange G) gel loading buffer was prepared and. electrophoresis was done 
on an agarose gel (1.2%) using 1 × TBE buffer. Electrophoresis was 
carried out at 5 V/cm for 30 min. Gels were stained with ethidium 
bromide (0.5µg/ml) and then visualized by using a ultra-violet (UV) 
transilluminator (300 nm).  
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2.3.3. QUANTIFICATION OF EXTRACTED DNA 
 
Purity and concentration of the extracted DNA was determined by the 
ratio of absorbance at 260 nm and 280 nm using a UV spectrophotometer. 
The concentration was calculated using the 260 nm absorbance reading (1 
optical density (OD) unit at 260 nm corresponds to 50 µg/ml double-
stranded DNA) (Sambrook et al., 1989). 
 
 DNA concentration (µg/ml) = A260 × 50 / 2(volume factor)  × 2(dilution 
factor) 
 
The purity of DNA extraction was determined by the ratio of OD at 260 
nm to 280 nm. 
 
 Purity = A260 / A280 
 
According to Sambrook et al. (1989), a ratio of 1.8 is the estimation for 
pure DNA quality. 
 
 
2.4. POLYMERASE CHAIN REACTION (PCR) 
ANALYSIS 
 
To amplify ND1and ND2 mitochondrial genes, 2 sets of PCR primers 
were designed, which were located in the flanking regions of each gene. 
  
Primer Design: Primers were based on the human mitochondrial 
sequence from the Entrez database; accession number NC_001807, 
provided by the National Centre of Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov). The computer program Primer 3 
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(http://www.path.com.ac.uk./cgi.bin/primer3.cgi) was used to design the 
primer sets to amplify the ND1 and ND2 genes. The criteria for the 
primer design were the product size, the primer size, GC content and 
melting temperature (Tm). The oligonucleotide primers were chemically 
synthesized by Invitrogen (Auckland, NZ). The properties of the primers 
are shown in table 2.2. 
 
 
Table 2.2: Primer pairs used to amplify ND1 and ND2 gene. 
 
 
Primer 
name 
Genomic 
location (bp) 
          Sequence (5’- 
3’) 
GC 
con
tent 
Tm 
(1 m 
Na+) 
Product 
size 
ND1 F 
ND1 R 
3245-3264 
4370-4351 
ccccggtaatcgcataaaact 
ttttggattctcagggatgg 
45% 
45% 
66oC 
66oC 
1125bp 
 
ND2 F 
ND2 R 
4382-4402 
5565-5545 
cctatcacaccccatcctaaa 
tgcaacttactgagggctttg 
47% 
47% 
69oC 
69oC 
1183bp 
 
F= Forward primer, R= Reverse primer, bp= base pair position related to the reference 
human mitochondrial sequence (accession number NC_001807). 
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2.4.1. PCR REACTION   
 
To amplify the ND1 and ND2 genes PCR reactions were optimized for 
each primer pair with different annealing temperature as shown in Table 
2. Approximately 160 ng of total sperm DNA was used in 50 µL of 
reaction mixture. The PCR reaction mixture contained 1.5 µM Mg+2, 200 
µM of deoxynucleotide triphosphate (dATP, dCTP, dTTP, dGTP), 1 × 
Taq buffer, 0.6 µM of each primer and 1 unit of Taq DNA polymerase 
(Roche). A standard PCR cycle was used initial denaturing at 94º C for 2 
min, followed by 35 cycles of denaturing at 94º C for 30 sec, 58º C of 
annealing for 45 sec and extension of primers at 72º C for 2 min. The 
final extension was at 72º C for 5 min and reaction products were stored 
at 4º C.  
 
2.4.2. VISUALIZATION OF PCR PRODUCTS 
 
To confirm the presence of PCR product 3µL of the PCR reaction 
mixture was analyzed by electrophoresis on a 1.2% agarose gel using 1 × 
TBE buffer. Electrophoresis was carried out at 5 V/cm for 30 min. Gels 
were stained with ethidium bromide (0.5µg/ml) and then DNA was 
visualized using a ultra-violet (UV) transilluminator (300 nm). 
 
 
2.4.3. PURIFICATION OF PCR PRODUCTS 
 
To remove unused primers and dNTPs, PCR products were purified by 
gel band excision. The purified PCR products were separated by 
electrophoresis and stained with ethidium bromide. The bands were 
excised from the agarose gel and purified using a GFX-PCR DNA and 
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gel band purification kit (Amersham Bioscience) according to the 
manufacturer’s instruction.  
 
 
2.4.4. VISUALIZATION OF PURIFIED PCR PRODUCTS 
 
Three microlitres of each purified PCR products were electrophoresed on 
1.2% agarose gel using 1 × TBE buffer. Electrophoresis was carried out 
at 5V/cm for 30 min. Gels were then stained with ethidium bromide and 
visualized using an UV transilluminator (300nm). 
 
 
2.5. DNA SEQUENCING 
 
Automated DNA sequencing was performed using the Applied Bio 
System Big DyeTM termination V 3.1 cycle sequencing kit. The mtDNA 
samples of different fertility groups were sequenced for both ND1 and 
ND2 gene. 
 
 
2.5.1. ADDITIONAL PRIMERS FOR SEQUENCING 
 
To get the whole sequence for every sample some additional primers 
were designed with reduced length and are shown in Table 2.3. 
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Table 2.3: Additional primers for sequencing for ND1 Gene. 
 
Primer 
name 
Genomic 
location 
(bp) 
          Sequence (5’- 3’) GC 
content 
Tm (1 
m Na+) 
ND1 FI 
ND1 R2 
ND1 R3 
3777-3796 
3668-3648 
3948-3929 
tggctcctttaacctctcca 
caccctgatcagaggattga 
attcgatgttgaagcctgaga 
 
50% 
50% 
42% 
66oC 
68oC 
67oC 
ND2 R2 
ND2 R3 
4884-4865 
5318-5289 
tgggggctagtttttgtcat 
gtggggatgatgaggctatt 
45% 
50% 
66oC 
68oC 
 
F= Forward primer, R= Reverse primer, bp= base pair position related to the reference 
human mitochondrial sequence (accession number NC_001807). 
 
 
2.5.2. AUTOMATED SEQUENCING 
 
All sequencing reactions were carried out in 20 μl of sequencing reaction 
mix containing 0.5μl of BDT (Big DyeTM), 1.75 μl of 5X sequencing 
buffer, 1 μl of primer (stock concentration: 3.2 μM), 2.5 μl of purified 
PCR products and 10 μl of ddH2O. 
 
Thermal cycle sequencing reactions were carried out on the thermal cycle 
(mastercycle@gradient.Eppendroff) with the following cycle parameters: 
960C of initial denaturing temperature of 10s, 500C of annealing 
temperature of 10s and 600C of primer extension temperature for 1.5 min. 
This thermal cycle was repeated for 25 times.  
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2.5.3. SEQUENCING REACTION CLEAN UP 
 
Sequencing products were purified using sequencing cleanup plates 
(Whatman unifilter filtration GF/C 800 # 1 long drip detector microplates 
(Global)). The clean up plate wells contained a column of sephadex resin 
beads. Sequencing reactions were applied to each well according to the 
protocol. The plate was centrifuged at 750 × g for 5 min for several times. 
Then the plate was then sealed with PCR sealing film and ready to go for 
automated sequencing in ABI PRISM, 3100 genetic analyzer using Big 
DyeTM termination V 3.1 cycle sequencing kit (Applied Bio System). 
 
 
2.5.4. EVALUATION OF DNA SEQUENCE 
 
All the data obtained from automated sequence was edited with a 
computer based program SequencherTM. These sequences were compared 
with the reference sequence (NCBI database, accession number: 
NC_00187) to determine the nature of mutations.  
 
 
Codon usage analysis for silent mutations 
 
The synonymous mutations were analyzed for codon usage. The results 
from this study and the data from Harris et al. 2006 were analyzed to 
predict the amino acid changes by the computer program MEGA version 
2.1 (Kumar et al., 2001). 
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Mutation analysis of non-silent mutations 
 
To determine the effect of changed amino acids on protein properties, the 
proteins were analyzed for hydrophobicity and polarity with computer 
based program (http://www.roselab.jhu.edu/~raj/MISC/hphobh.html) and   
ProtScal 
(http://download.invitrogen.com/evergreen/support_files/a_protscale_exp
asy.htm) respectively. 
 
 
Statistical analysis of different mutations 
 
The Z value was determined for testing for significant differences 
between the mutants/polymorphisms in the sets of fertile and subfertile 
men which were identified in at least 3 samples. The Z value was 
calculated from Daniel (1999). 
 
The Chi-square (χ2) test was used to determine the significant difference 
between the lower and higher relative codon usage value of the 
synonymous mutations at 5% level of significance. The Chi-square (χ2) 
test was calculated from Walpole (1982). 
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RESULTS 
 
3.1. DNA EXTRACTION  
 
Genomic DNA was extracted from 157 semen samples with various 
fertility statuses (Appendix 3). The table below shows the total number of 
samples used in this study. These samples were classified to different 
groups according to the World Health Organization (1999). Figure 3.1 
shows the DNA extracted from samples with different fertility status 
analyzed by electrophoresis.  
 
Table 3.1: Number of semen samples used in this study. 
 
 
 
 
Used in PCR and  
        Sequencing 
         Samples Total  
extracted 
samples ND1 ND2 
Normozoospermic  75  40  46 
Asthenozoospermic 43  28  28 
Oligozoospermic 10  5  6 
Oligoasthenozoospermic 11  3  5 
Severe oligozoospermic 6  2  3 
Severe  
oligoasthenozoospermic 
5  1  2 
Azoospermic 3  1  2 
Total number of                 78                        40                 46 
 non-normozoospermic                                                                      
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Fig 3.1: Genomic DNA from semen samples. Lane M: Lamda DNA 
marker digested with restriction enzymes, EcoRI and HindIII, lane 2-3: 
normozoospermic, lane 4-5: asthenozoospermic, lane 6: oligozoospermic, lane 
7: oligoasthenozoospermic, lane 8: severe oligozoospermic, lane 9: severe 
asthenoligozoospermic, lane 10: azoospermic.  
Electrophoresis was done on an agarose gel (1.2%) using 1 × TBE buffer and 
visualized using an ultra-violet (UV) transilluminator (300 nm).  
The expected sizes of the lambda DNA marker are in descending order, 21kb, 
5148bp, 4268bp, 3530bp 2027bp, 1904bp, 1584bp, 1375pb, 941bp, 831bp and 
564bp. 
 
 
3.2. AMPLIFICATION OF mtDNA 
 
PCR reactions were performed to amplify the ND1 and ND2 genes from 
the extracted DNA samples. Among them, 80 samples showed the proper 
PCR product size (1125 bp) with ND1 gene and 92 samples showed the 
correct PCR product size (1183 bp) with ND2. Figure 3.2 shows the 1125 
bp PCR product of ND1 for 8 samples Similarly, Figure 3.3 shows ND2 
PCR products for 7 samples. 
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Fig 3.2: PCR products of ND1.  Lane M: Lambda DNA marker digested with 
restriction enzymes, EcoRI and HindIII,, lane 1: Positive control (sample containing 
extracted DNA of correct PCR product size for ND1), lane 2: negative control (sample 
without extracted DNA), lane 3: normozoospermic, lane 4-5: asthenozoospermic, lane 6: 
oligozoospermic, lane 7: oligoasthenozoospermic, lane 8 severeoligozoospermic, lane 9: 
severeasthenoligozoospermic, lane 10: azoospermic.  
Electrophoresis was done on an agarose gel (1.2%) using 1 × TBE buffer and visualized 
by using an ultra-violet (UV) transilluminator (300 nm). The expected sizes of lambda 
DNA marker are in descending order, 21kb, 5148bp, 4268bp, 3530bp, 2027bp, 1904bp, 
1584bp, 1375pb, 941bp, 831bp and 564bp. 
 
 
 
Fig 3.3: PCR products of ND2.  Lane M: Lambda DNA marker digested with 
restricted enzymes, EcoRI and HindIII,, lane 1: Positive control (sample containg 
extracted DNA of correct PCR product size for ND2), lane 2: negative control (sample 
without extracted DNA), lane 3: normozoospermic, lane 4: asthenozoospermic, lane 5: 
oligozoospermic, lane 6: oligoasthenozoospermic, lane 7: severe oligozoospermic, lane 
8: severe asthenoligozoospermic, lane 9: azoospermic. 
Electrophoresis was done on an agarose gel (1.2%) using 1 × TBE buffer and visualized 
by using an ultra-violet (UV) transilluminator (300 nm). The expected sizes of lambda 
DNA marker are in descending order, 21kb, 5148bp, 4268bp, 3530bp, 2027bp, 1904bp, 
1584bp, 1375pb, 941bp, 831bp and 564bp. 
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3.3. PCR PRODUCT PURIFICATION 
 
Figure 3.4 shows 10 purified PCR products of ND1. Similarly, 10 
purified ND2 PCR products were shown in Fig 3.5.  
 
 
 
Fig 3.4: Purified ND1 PCR products. Lane M: Lambda DNA marker, lane 1: Positive control 
(sample containg extracted DNA of correct purified PCR product size for ND1), lane 2: 
normozoospermic, lane 3-4: asthenozoospermic, lane 5-6: oligozoospermic, lane 7: 
oligoasthenozoospermic, lane 8-9: severeoligozoospermic, lane 10: severeasthenoligozoospermic, 
lane 11: azoospermic.  
Electrophoresis was done on an agarose gel (1.2%) using 1 × TBE buffer and visualized by using 
an ultra-violet (UV) transilluminator (300 nm). The expected sizes of lambda DNA marker are in 
descending order, 21kb, 5148bp, 4268bp, 3530bp, 2027bp, 1904bp, 1584bp, 1375pb, 941bp, 
831bp and 564bp. 
 
 
 
Fig 3.5: Purified ND2 PCR products. Lane M: Lambda DNA marker, lane 1: Positive control 
(sample containg extracted DNA of correct purified PCR product size for ND2), lane 1-2: 
Normozoospermic, lane 3-4: asthenozoospermic, lane 5-6: oligozoospermic, lane 7: 
oligoasthenozoospermic, lane 8-9: severeoligozoospermic, lane 10: severeasthenoligozoospermic, 
lane 11: azoospermic.  
Electrophoresis was done on an agarose gel (1.2%) using 1 × TBE buffer and visualized by using 
an ultra-violet (UV) transilluminator (300 nm). The expected sizes in lambda DNA marker are in 
descending order, 21kb, 5148bp, 4268bp, 3530bp, 2027bp, 1904bp, 1584bp, 1375pb, 941bp, 
831bp and 564bp. 
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3.4. DNA SEQUENCE ANALYSIS 
 
3.4.1. ND1 gene 
 
After purification of PCR products automated DNA sequencing was 
performed using the Applied Bio System Big DyeTM termination V 3.1 
cycle sequencing kit. Eighty samples of different fertility groups were 
sequenced for the ND1 gene. These sequences were compared with the 
reference sequence obtained from the NCBI database (accession number: 
NC_001807). A computer software program SequencherTM was used to 
edit the sequences and determine the nature of mutations. Several 
mutations in different nucleotide position in ND1 region were found in 
different groups of the samples. The base substitutions were located at 
nucleotides (nts) 3396, 3450, 3480, 3567, 3591, 3594, 3666, 3693, 3992, 
4024 and 4216 (Table 3.3). 
 
 
SNP T3396C 
A T to C transition was identified at nt 3396 in the ND1 gene. This SNP 
was found in a normozoospermic man (sample code, 010573). This SNP 
is a synonymous substitution in the third position of a tyrosine codon, 
changing it from TAT to TAC (Fig 3.6A and 3.6B) (Table 3.3). 
 
SNP C3450T 
A C to T transition was identified at nt 3450 in ND1 region. This 
transition was observed in an oligoasthenozoospermic (sample code, 
6445) sample (figure not shown). This SNP, a synonymous substitution, 
occurred in the third position of the proline codon, changing the codon 
CCC to CCT (Table 3.3). 
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Fig 3.6. A Chromatogram of control sample at nt 3396. B shows T3396C in sample 
010573 a normozoospermic sample. 
 
 
SNP A3480G  
An A to G transition was identified at nt 3480 in the ND1 gene. This SNP 
was found in four samples in different fertility groups. This transition was 
observed in 1 normozoospermic (sample code, 010081), 2 in 
asthenozoospermic (sample code, 010480, 2495) and 1 in oligozoospermic 
(sample code, 2902) samples (Fig 3.7). This SNP was a synonymous 
substitution occurring in the third position of the lysine codon, changing the 
codon from AAA to AAG (Table 3.3).  
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Fig: 3.7. A shows Chromatogram of control sample at nt 3480. B and C are from 
asthenozoospermic samples (010480, 2495), D from oligozoospermic (2902) sample and E 
from normozoospermic (010081) sample show transition of A to G at nt 3480. 
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SNP G3591A 
 
A G to A transition was identified at nt 3591 in the ND1 region. This 
transition was observed in an oligozoospermic sample (sample code, 
010208, figure not shown). This SNP is a synonymous substitution that 
occurred in the third position of leucine codon, changing the codon CTG 
to CTA (Table 3.3). 
 
SNP C3594T 
 
A C to T transition was identified at nt 3594 in the ND1 gene. This SNP 
was found in a normozoospermic (sample code, 010573) sample. This 
SNP is a synonymous substitution occurring in the third position of the 
valine codon, changing the codon from GTC to GTT (Fig 3.8C and 3.8D) 
(Table 3.3). 
 
 
 Fig: 3.8. C shows chromatograms of control sample at nt 3594 respectively D shows C3594T 
respectively in sample 010573, a normozoospermic sample. 
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SNP G3666A 
 
A G to A transition was identified at nt 3666 in the ND1 region. This SNP 
was found in a normozoospermic sample (sample code, 010573) and was a 
synonymous substitution occurring in the third position of the glycine 
codon, changing the codon from GGG to GGA (Fig 3.9) (Table 3.3).  
 
 
 
 
Fig 3.9: A Chromatogram of control sample at nt 3666. B shows G3666A in a 
normozoospermic sample 010573. 
 
 
 
SNP G3693A 
A G to A transition was identified at nt 3693 in the ND1 gene. This SNP 
was found in a normozoospermic sample (sample code, 010573). This SNP 
is a synonymous substitution occurring in third position of the leucine 
codon, changing the codon from CTG to CTA (figure not shown) (Table 
3.3).  
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SNP C3992T 
A C to T transition was identified at nt 3992 in ND1 gene. This SNP was 
found in a sample of a severely oligozoospermic man (sample code, 
010639) (Fig 3.11). This SNP is a non-synonymous substitution that 
occurred in the second position of the threonine codon, changing the codon 
from ACA to ATA. A C to T transition at nt 3992 changed methionine 
(ATA) to threonine (ACA) (Table 3.4). The secondary structures of each 
residue in an amino acid sequence were predicted by computer program 
nnpredict (http://www.cmpharm.ucsf.edu/~nomi.nnpredict.). 
 
                                                                          nt 3992                                      
                                                            
                                                                  ↓                                                               
       Normal Sequence:   G C C G A A T A C A C A A A C A T T A T T A T A 
    Variant Sequence:  G C C G A A T A T A C A A A C A T T A T T A T A 
                   Secondary structure predicting 
     ↓ 
        Normal Sequence:        - - - - - - H H H H H H H H H – H H H – H - - - 
    Variant Sequence:        - - - - - - H H H H H H H H H – H H H – H - - - 
 
(H = helix, E = strand, - = no prediction, tertiary structure 
class: alpha/beta)  
Fig: 3.10.  nnpredict of human ND1 protein at nt 3992. 
nnpredict (http://www.cmpharm.ucsf.edu/~nomi.nnpredict.) is a 
computer program that predicts the secondary structure type of 
each residue in an amino acid sequence. However, when change 
the parameter to use alpha/beta tertiary structure, the structure 
remains almost the same. 
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Fig 3.11. A: Chromatogram of control sample at nt 3992. B shows C3992T transition in, a 
severely oligozoospermic (sample code, 020639) sample. 
 
 
SNP A4024G 
An A to G transition was identified at nt 4024 in the ND1 region. This 
transition was observed in a severely oligozoospermic (sample code, 
010639) sample (Fig 3.12). This SNP is a synonymous substitution 
occurred in the third position of leucine codon, changing from the codon 
CTA to CTG (Table 3.3). 
 
 
 
Fig 3.12. A: Chromatogram of control sample at nt 4024. B shows A4024G transition in 010639, a 
severely oligozoospermic sample. 
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SNP T4216C 
 
A T to C transition was identified at nt 4216 in the ND1 region. This 
transition is observed in one normozoospermic (sample code, SF 96-229) 
and 2 asthenozoospermic (sample code, 010545, 2409, figure not shown) 
(Fig 3.14) samples. This non-synonymous substitution occurred in the first 
position of tyrosine codon, changing the codon from TAT (tyrosine) to 
CAT (histidine) (Table 3.4). The secondary structures of each residue in an 
amino acid sequence were predicted by computer program nnpredict 
(http://www.cmpharm.ucsf.edu/~nomi.nnpredict.). 
                                                              nt 4216 
                                                       ↓                                                               
Normal Sequence:   T T A C T T A T A T G A T A T G T C T C C A T A  
Variant Sequence:    T T A C T T A C A T G A T A T G T C T C C A T A 
                                
                                     Secondary structure predicting 
                                                      ↓ 
Normal Sequence:        - - - - - - H H – H - - - - - - - - - - - - - - 
Variant Sequence:          - - - - - - H H - - - - - - - - - - - - - - - - 
 
(H = helix, E = strand, - = no prediction, tertiary structure 
class: alpha/beta)  
Fig: 3.13.  nnpredict of human ND1 protein at nt 4216. 
nnpredict (http://www.cmpharm.ucsf.edu/~nomi.nnpredict.) is a 
computer program that predicts the secondary structure type of 
each residue in an amino acid sequence. However, when change 
the parameter to use alpha/beta tertiary structure, the structure 
remains almost the same. 
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 Fig 3.14. A: Chromatogram of control sample at nt 4216. B shows T4216C transition in 
SF96-229, a normozoospermic. C shows T4216C transition in 010545 an 
asthenozoospermic sample. 
 
 
3.4.2. ND2 gene 
 
Ninety two samples from different fertility groups were sequenced for the 
ND2 gene. These sequences were compared to the reference sequence, in 
the NCBI database (accession number: NC_001807). A computer 
software program SequencherTM was used to edit the sequences and 
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determine the nature of mutations. Two mutations were found in different 
fertility groups of the samples at different nucleotide position in this gene. 
The base substitutions were located at nucleotides (nts) 4514 and 4580 
(Table 3.3). 
 
 
SNP A4514G 
An A to G transition was identified at nt 4514 in the ND2gene. This 
transition was observed in a normozoospermic (sample code, 6383) (figure 
not shown), and in asthenozoospermic, sample code, 2409 and 5097(figure 
not shown) sample (Fig 3.15). This SNP is a synonymous substitution 
occurring in the third position of an alanine codon, changing the codon 
GCA to GCG (Table 3.3).  
 
 
Fig 3.15. A: Chromatogram of a control sample at nt 4514 in ND2 region. B shows 
A4514G transition in 2409, an asthenozoospermic sample. 
 
 
 
 
 
 
                                                                                      53
   
SNP G4580A 
A G to A transition was identified at nt 4580 in the ND2 region. This 
transition was observed in three normozoospermic sample (sample code, 
010081, (figure not shown), 010526 (figure not shown) and 6750), in one 
oligoasthenozoospermic sample (sample code, 009593) and in one 
oligozoospermic (sample code 010830) sample (Fig 3.16). This SNP is a 
synonymous substitution that occurred in the third position of methioninie 
codon, changing the codon from ATG to ATA (Table 3.3).  
 
 
 
 
Fig 3.16. A: Chromatogram of a control sample at nt 4580 in the ND2 region. B shows nt 
4580 transition in normozoospermic (6750) sample. C and D show the G4580A transition in 
an oligozoospermic (010830) and oligoasthenozoospermic (009593) sample.  
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3.5. STATISTICAL ANALYSIS 
 
A statistical analysis was performed on individual SNPs that were 
identified in at least 3 samples of the total fertile and subfertile 
population. The Z value was determined for testing for significant 
differences between the mutants/polymorphisms in the sets of fertile and 
subfertile men (Table 3.2). 
 
The Z value was calculated from Z = | P1 - P2 | / √ (P (1-P)/n) (Daniel, 
1999). 
Where, P1= x1/n1, P2= x2/n2, n=n1+n2, P= (n1P1 + n2P2)/ (n1+n2), x1= 
number of mutants in fertile group, x2 = number of mutants in subfertile 
group, n1= total number of fertile men, n2= total number of subfertile 
men. 
 
Table 3.2. Statistical analysis of different mutants in both ND1 and 
ND2 genes. 
 
SNPs Gene P1(Fertile 
Men) 
P2(Infertile 
Men) 
Z-Value 
A3480G ND1 1/40 3/40 0.2236 
 T4216C ND1 1/40 2/40 0.1290 
G4580A ND2 3/46 2/46 0.0932 
A4514G ND2 1/46 2/46 0.1203 
 
In all the four cases, z-values were less than the 5% value (z=1.96 at 5% 
level of significance). Therefore the observed differences in all the four 
mutants were not significant. 
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3.6. ANALYSIS OF CODON USAGE IN SYNONYMOUS 
MUTANTS IN MITOCHONDRIAL DNA 
 
 
The frequency of codon usage for each mitochondrial gene was 
determined using the computer program MEGA version 2.1 (Kumar et 
al., 2001). The amino acid and their frequency change rate were 
determined. Data obtained from a previous study (Harris et al., 2006) has 
also been analyzed for codon usage. Analyses of codon usage in 
synonymous mutants from this study and from Harris et al. (2006) are 
tabulated in Table 3.3. 
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Table 3.3: DNA sequence analysis and the codon usage of 
synonymous mutations in different groups of semen samples in mt 
DNA. 
 
Classifica 
tion 
 gene Samples Spm 
 Cnt 
(M/ml) 
Motility 
% 
Mutation Codon Change Amino  
Acid 
 change 
Codon 
frequency  
change 
Codon  
frequency 
change 
 rate 
N ND1 010573* 
 
 
 
 010081* 
  
 
93 
 
 
 
109 
 
 
62 
 
 
 
53 
 
T3396C* 
C3594T* 
G3666A*    
G3693A* 
A3480G* 
 
 
TAT?TAC 
GTC?GTT 
GGG?GGA 
CTG?CTA 
AAA?AAG 
 
Silent 
Silent 
Silent 
Silent 
Silent 
 
1.63?1.60 
2.00?0.80 
1.00?.033 
0.48?1.57 
1.71?0.29 
 
 
 
 
 
 
Lower 
Lower 
Lower 
Higher 
Lower 
 
 
As ND1 010480* 
2495* 
 
70 
24 
 
24 
31 
 
A3480G* 
A3480G* 
 
AAA?AAG 
AAA?AAG 
 
Silent 
Silent 
 
1.71?0.29 
1.71?0.29 
 
Lower 
Lower 
 
 
So ND1 010639* 
 
  
1 
 
 
4 
 
 
A4024G*  
 
CTA?CTG 
 
 
Silent 
 
 
2.57?0.48 
 
 
Lower 
 
 
 
O ND1 010208* 
2902* 
6768* 
4.6 
3.2 
3.8 
22 
35 
38 
G3591A* 
A3480G* 
C3567T* 
CTG?CTA 
AAA?AAG 
ACC?ACT 
Silent 
Silent 
Silent 
0.48?2.57 
1.71?0.29 
2.29?0.11 
Higher 
Lower 
Lower 
 
 
OAs ND1 6445* 9.3 39 C3450T* CCC?CCT 
 
Silent 
 
3.09?0.36 
 
Lower 
 
 
N ND2 010081* 
010526* 
6570* 
6383* 
109 
109 
75 
70 
53 
636 
79 
56 
G4580A* 
G4580A* 
G4580A* 
A4514G 
ATG?ATA 
ATG?ATA 
ATG?ATA 
GCA?GCG 
Silent 
Silent 
Silent 
Silent 
0.17?1.83 
0.17?1.83 
0.17?1.83 
1.60?0.60 
Higher 
Higher 
Higher 
Lower 
 
As ND2 2409* 
5097* 
55 
65 
28 
37.2 
A4514* 
A4514G* 
GCA?GCG 
GCA?GCG 
Silent 
Silent 
1.60?0.60 
1.60?0.60 
Lower 
Lower 
 
O ND2 010830* 46 15 G4580A* ATG?ATA Silent 0.17?1.83 Higher 
 
OAs ND2 009593* 21 50 G4580A* ATG?ATA Silent 0.17?1.83 Higher 
Az ND1 2473 0 0 A3480G AAA?AAG Silent 1.71?0.29 lower 
Az ND1 4071 0 0 A3480G AAA?AAG Silent 1.71?0.29 lower 
SOAs ND1 4110 5 18 A3480G AAA?AAG silent 1.71?0.29 lower 
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O ND1 5597 16.8 53 A3480G AAA?AAG Silent 1.71?0.29 lower 
Az COXI 2473 0 0 G6260A GAG?GAA Silent  0.6?1.40 Higher 
As COXI 2772 24 30 T6911G GCT?GCG Silent 1.20?0.10 lower 
As COXI 5415 161 41 T6911G GCT?GCG Silent 1.20?0.10 lower 
As COXII CCR 42 33 G7853A GTC?ATC Silent 2.15?1.36 Lower 
As COXII QD747V 34 29 G8251A GTC?ATC Silent 1.45?1.45 - 
As COXII QR509H 222 57 G8251A GTC?ATC Silent 1.45?1.45 - 
As COXII 94-150 26 19 G8251A GTC?ATC Silent 1.45?1.45 - 
N COXII SF95-122 115 62 G8251A GTC?ATC Silent 1.45?1.45 - 
As COXII SF96-279 65 30 C7819A CTC?CTA Silent 2.40?1.78 lower 
As COXII QD788L 85 50 G7789A CTG?CTA Silent 0.55?2.18 Higher 
SOAs COXIII CD 0.65 8 G9380A TGG?TGA Silent 0.67?1.33 Higher 
O COXIII AM472M 19.80 57 G9380A TGG?TGA Silent 0.67?1.33 Higher 
N COXIII AM235Q 190 51 G9380A TGG?TGA Silent 0.67?1.33 Higher 
Az ND6    4449 0 0 G14581A ATG?ATA Silent 
 
1.6?0.4 Higher 
Lower 
As ND6     AT665c 51 29 G14581A ATG?ATA Silent 
 
1.6?0.4 Higher 
Lower 
Az ND6    2473 0 0 G14581A ATG?ATA Silent 
 
1.6?0.4 Lower 
As ND6    6169 70.40 56 G14581A ATG?ATA Silent 
 
1.6?0.4 Higher 
 
Az hND2 3008 0 0 C5360G ATC?ATG Silent 1.50?0.17 Lower 
OAs ND5 CP 4.6 32 G13368A CGG?CGA Silent 0.0?1.50 Higher 
SO ND5 2578 2.5 70 G12618A TTG?TTA Silent 1.50?0.78 Lower 
OAs ND5 2703 10.6 15 G12618A TTG?TTA Silent 1.50?0.78 Lower 
N h ND1 SF 94_97 86 72 C3414G GCC?GCG Silent 2.07?2.67 Higher 
N h ND1 QR 509H 75 82 C3414G GCC?GCG Silent 2.07?2.67 Higher 
N ATPase6 SF96_305 52 55 A9150G TTA?TTG Silent 0.55?0.14 Lower 
As ATPase6 94-149 34 40 A9150G TTA?TTG Silent 0.55?0.14 Lower 
OAs ATPase6 SF362 15.5 26 A9150G TTA?TTG Silent 0.55?0.14 Lower 
As ATPase6 QD747V 34 41 G8856A GCG?GCA Silent 0.19?0.76 Higher 
0 ND4L 
 
ND4 
 
 
 
ND4/ND5 
ND5 
 
5378 8 16.80 A10551G 
 
C10874T 
C11018T 
A11468G 
A12309G 
 
G12373A 
T12706C 
 
ATA?ATG 
 
CTA?TTA 
AGA?AGT 
AAA?AAG 
AAA?AAG 
 
CTG?CTA 
ATT?ATC 
 
Silent 
 
Silent 
Silent 
Silent 
INTRON 
 
Silent  
Silent 
 
1.80?0.20 
 
2.63?0.50 
1.26?0.14 
1.64?0.36 
 
 
0.46?2.0 
0.72?1.28 
 
Lower 
 
Lower 
Lower 
Lower 
 
 
Higher 
Higher 
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O ND4L 
 
ND4 
 
 
 
ND4/ND5 
ND5 
 
JN 3.4 18 A10551G 
 
C10874T 
C11018T 
A11468G 
A12309G 
 
G12373A 
 
ATA?ATG 
 
CTA?TTA 
AGA?AGT 
AAA?AAG 
AAA?AAG 
 
CTG?CTA 
 
Silent 
 
Silent 
Silent 
Silent 
INTRON 
 
Silent  
 
1.80?0.20 
 
2.60?0.40 
1.26?0.14 
1.64?0.36 
 
 
0.46?2.0 
 
Lower 
 
Lower 
Lower 
Lower 
 
 
Higher 
 
Az  
 
ND4 
 
 
 
 
 
3008 0 0  
C10874T 
C11018T 
 
 
 
 
 CTA?TTA 
AGA?AGT 
 
 
 
Silent 
Silent 
 
 
 
2.60?0.40 
1.26?0.14 
 
 
 
 
 
Lower 
Lower 
Lower 
 
 
 
 
 
 
SOAs ND4L 
 
ND4 
 
 
 
ND4/ND5 
ND5 
 
TI 4.8 32 A10551G 
 
C10874T 
A11468G 
G11915A 
A12309G 
 
G12373A 
T12706C 
T13327C 
 
ATA?ATG 
 
CTA?TTA 
AAA?AAG 
ACG?ACA 
AAA?AAG 
 
CTG?CTA 
ATT?ATC 
TGT?TGC 
 
Silent 
 
Silent 
Silent 
Silent 
INTRON 
 
Silent  
Silent 
Silent 
 
1.80?0.20 
 
2.60?0.40 
1.64?0.36 
0.8?1.40 
 
 
0.46?2.0 
0.72?1.28 
0.33?1.67 
 
Lower 
 
Lower 
Lower 
Higher 
 
 
Higher 
Higher 
Higher 
 
N ND3 
 
ND4L 
 
ND4 
 
 
 
ND4/ND5 
ND5 
 
2905 135 64 A10290G 
 
A10551G 
 
C10874T 
 
A12309G 
 
G12373A 
T12706C 
G12502A 
TGA?TGC 
 
ATA?ATG 
 
CTA?TTA 
 
AAA?AAG 
 
CTG?CTA 
ATT?ATC 
ATG?ATA 
Silent 
 
Silent 
 
Silent 
 
INTRON 
 
Silent  
Silent 
Silent 
1.83?0.17 
 
1.80?0.20 
 
2.60?0.40 
 
 
 
0.46?2.0 
0.72?1.28 
0.23?1.77 
Lower 
 
Lower 
 
Lower 
 
 
 
Higher 
Higher 
Higher 
* Indicates the mutations obtained from different groups of semen samples                  
from this study. Other samples were analyzed from Harris et al 2006. As= 
Asthenozoospermic, Az= Azoospermic, OAs= Oligoasthenozoospermic, SOAs= 
Severely oligozoospermic, So= Severely oligozoospermic, O= Oligozoospermic and N= 
Normozoospermic samples. 
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3.7. ANALYSIS OF NON-SYNOMYMOUS MUTATIONS 
 
Two non-synonymous (T4216C and C3992T) mutations were found in 
this study (Table 3.4). These mutations were also analyzed for 
hydropathicity and polarity value. These hydropathicity and polarity 
values were compared with that of the normal amino acid sequence. 
According to Kyte and Doolittle (1982), the hydropathicity readings are 
the measurement of the ability of polypeptides to interact with water. If 
the value was below zero, then the amino acid was hydrophilic, otherwise 
it was hydrophobic. The polarity reading was assessed by the change of 
the amino acid. If the reading was above ten, then the amino acid was 
basic or acidic. If the reading was in between five to seven then it was 
nonpolar (Granthum, 1974). The hydrophathicity and polarity values for 
all the non-synonymous mutations from this study are tabulated in Table 
3.5. 
 
Table 3.4: DNA sequence analysis of non-silent mutants in different 
groups of semen samples.  
 
 
Classifica 
tion 
Gene Samples Spm  
Cnt 
(M/ml) 
Motility 
% 
Mutation Codon change Amino  
Acid  
change 
N ND1 SF 96-229 
 
75 50 T4216C 
 
TAT?CAT 
 
Tyr?His 
 
As ND1 2409 
010545 
 
55 
74 
28 
19 
T4216C 
T4216C 
TAT?CAT 
TAT?CAT 
 
Tyr?His 
Tyr?His 
 
So ND1 010639 
 
  
1 
 
 
4 
 
 
 C3992T 
 
ACA?ATA 
 
Thr?Met 
 
Here, As= Asthenozoospermic, So= Severe oligozoospermic and N= 
Normozoospermic samples. 
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Table: 3.5. Hydropathicity and polarity analysis of non-silent 
mutants. 
 
 
Hydropathicity        Polarity Cla
ssifi 
cati
on 
Gene Sample Mutation Codon 
 change 
Amino 
acid 
 change 
Norm
al 
varia
nt 
Norm
al 
varia
nt 
N 
 
As 
ND1 SF 96-
229 
2409 
010545 
 
T4216C 
 
TAT?CAT 
 
Tyr?His 
 
1.222 1.011 6.211 6.678 
So ND1 010639 
 
C3992T 
 
ACA?ATA 
 
Thr?Met 
 
0.622 0.911 7.300 7.622 
 
Here, As= Asthenozoospermic, So= Severe oligozoospermic and N= 
Normozoospermic samples. 
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DISCUSSION 
 
 
4.1. MUTATION DETECTION BY PCR AND 
AUTOMATED DNA SEQUENCING 
 
 
Possible mutations within a nucleotide sequence can be detected by 
various methods. Polymerase chain reaction (PCR) is one of the unique, 
uncomplicated and rapid techniques that can amplify millions of copies 
of a gene from just one starting molecule (Brown et al., 1995). The 
importance of PCR can be demonstrated by the successful amplification 
of DNA from an isolated sperm cell, containing just one haploid copy of 
a human genome or a few mitochondria (Brown et al., 1995; Holyoake et 
al., 1999). Thus, its ease of application and reliability allows it to be 
widely used in genetic screening and research (Klug and Cummings, 
1997).  
 
In this study, ND1 and ND2 gene were amplified from 80 and 92 semen 
samples, respectively, from different fertility groups.  
 
For this study, all the PCR products were sequenced with forward and 
reverse primers, and the mutations were confirmed by at least two or 
more sequencing reactions.  
 
 
4.2. MITOCHONDRIAL DNA REPLICATION ERROR 
 
The mutation rate of mitochondrial DNA has been estimated to be 10 fold 
higher than that of nuclear DNA (Copeland et al., 2002). The presence of 
mutations are  associated with various human diseases (Wallace, 1992; 
 
                                                                                      63
   
1994; 1999; Torroni et al., 1996; Wallace et al., 1999; Shanske et al., 
2001; Copeland et al., 2002; DiMauro et al., 2003; Houshmand, 2003; 
Leob et al., 2005). Fidelity of mtDNA replication is important. 
Mitochondria appear to lack an efficient DNA repair system compared 
with the nuclear DNA replication system. Mitochondrial DNA also lack 
of protection of histone protein. Thus, mutations may result from DNA 
damage caused by external factors (Copeland et al., 2002). Mitochondrial 
DNA polymerase (poly γ) is the only DNA polymerase that resides in 
mitochondria (Leob et al., 2005). Poly γ is responsible for mtDNA 
synthesis including replication of mitochondrial genome and repair of 
DNA damage (Leob et al., 2005). Expression of a mutated version of the 
poly γ gene results in the accumulation of mutations in mtDNA 
(Spellbrink et al., 2002). The error rates for the human mitochondrial 
DNA poly γ are higher than those of chicken and pig DNA polymerase γ 
(Kunkel et al., 1988; Kunkel et al., 1989). Mice bearing mutant poly γ 
showed respiratory dysfunction in the absence of enhanced ROS 
production (Leob et al., 2005). Leob et al. (2005) suggested that 
mitochondrial mutations were generated by mutant polymerase γ during 
mtDNA replication. However, a recent study by Harris et al. (2006) has 
established that there was no relationship between the poly γ genotypes 
and SNP frequencies in normozoospermic and non-normozoospermic 
men. Therefore, mutations in ND1 and ND2 genes of the semen samples, 
which were found in this study, might not be caused by mtDNA 
replication error.  
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4.3. MUTATION ANALYSIS 
 
 
4.3.1. ND1 MUTATION SCREENING 
 
 
From this research 11 different mutations were identified in the ND1 
gene. Only two variants were present in more than one sample. An A to 
G transition at nt 3480 was found in the ND1 gene in both 
normozoospermic and non-normozoospermic (asthenozoospermic and 
oligozoospermic) men. Only 1 out of 40 (2.5%) normozoospermic men 
showed this mutation. But 3/40 (7.5%) subfertile men displayed the same 
A to G transition at nt 3480. The sperm motility for these three subfertile 
patients was around 30-35%, while that of the normozoospermic patient 
was 53%. A comparison with sperm motility of other normozoospermic 
men found that they all had a higher sperm motility of around 70% or 
greater. Could the A3840G mutation be the cause for low sperm motility?  
This A3480G transition was a silent mutation, which did not change the 
amino acid. Examination of the codon usage revealed that relative 
frequency of usage of the AAA codon is higher than AAG (1.71→0.29). 
Further, there are only 22 tRNAs in mitochondria. A change from a 
commonly used codon to a less commonly used codon may affect 
translation efficiency. This has been established by Duan et al. (2003). 
They demonstrated that a synonymous mutation in the human domain 
receptor D2 affects the folding of DRD2 mRNA. This mutation 
destabilized the mRNA structure and lowered the translation efficiency. 
Similarly, Smith et al. (2001) found in E. coli that less commonly used 
synonymous codons were maintained within the gene because of the 
ribosomal binding motif at the start of a gene affecting translation 
efficiency. 
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A T to C transition at nt 4216 in the ND1 gene found in different fertility 
groups in this study. One normozospermic man out of forty (2.5%) 
showed this transition. On the other hand 2/40 subfertile men (5%) were 
with T4216C mutation. This is a non-silent mutation which changes the 
amino acid from tyrosine to histidine. Both amino acids are hydrophobic 
and nonpolar. Secondary structure prediction of the proteins showed that 
the structure was still similar despite the change.  Hydrophobicity plots of 
proteins with changed amino acids as a result of nucleotide substitution 
could not affect the function of a protein (Holyoake et al., 2001). So the 
T4216C mutation might not have a severe effect on the function of ND1 
protein but it is still doubtful.  
Only one normozoospermic sample showed 4 different mutations in 4 
nucleotide positions (3396, 3594, 3666, and 3693) in the ND1 gene. No 
other normal semen samples used in this study showed these mutations. It 
is possible that these mutations were transmitted from his mother. But as 
his mother’s mtDNA genome was not available for examination it is not 
clear whether these mutants were inherited from his mother or de novo 
mutations. All these mutants are silent and their codon frequency change 
rates are lower except in nt 3693 for a G to A transition.  The sperm 
motility of this man was 62%. 
A severely oligozoospermic sample had an A to G silent transition at nt 
4024, and  a C to T non-silent transition at nt 3992 with an amino acid 
change from threonine to methionine. However, this mutation did not 
change the predicted secondary structure. The sperm count and sperm 
motility of this man were 1M/ml and 4%, respectively.   
Three silent mutants were also found in three different nucleotide 
positions (G3591A, C3567T and C3450T) in the ND1 gene in three 
different subfertile patients. Except for a G3591A transition mutation in 
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an oligozoospermic sample, the others displayed a reduced level of codon 
usage frequency.  
 
Overall the ND1 gene mutations occurred more in subfertile men than 
fertile men. All of the mutations appear to be associated with reduced 
sperm motility. Nine were synonymous and two (T4216C, C3992T) were 
non-synonymous (Table 3.3; Table 3.4). Of these, eight non-silent 
mutations from both fertile and sufertile groups were associated with 
reduced level of relative codon usage frequency (Table 4.2).  However, it 
is not known whether change in codon usage will affect translation 
efficiency.   
 
4.3.2. ND2 MUTATION SCREENINIG 
 
Two different mutations were identified in the ND2 gene from this 
research. A G to A transition was observed at nt 4580 in different 
samples of different fertility status. This mutation occurred in 6.5% of 
fertile men and 4.3% of subfertile men. The samples, included 
subnormozoospermic and normozoospermic men with this mutation had 
a motility range of 15-79%. As the occurrence rate of this mutation in the 
two groups was similar, this mutation might not be responsible for poor 
semen quality. Further this was a silent mutant with codon change from 
ATG to ATA. The relative frequency of codon usage rate for ATG and 
ATA is 0.17 and 1.83, respectively.  
 
A silent mutation in ND2 at nt 4514 was found in 2/46 (4.3%) subfertile 
men and 1/46 (2.2%) fertile men. The sperm motility for these two 
subfertile patients was 28% and 37%, while that of the normozoospermic 
patient was 56%.  The sperm motility of other normozoospermic men 
tended to be higher, greater than 70%. The A4514G mutation could be a 
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cause for low sperm motility. But this mutation might not be solely 
responsible for poor semen production in men. The relative frequency of 
codon usage rate was reduced from 1.60 to 0.60.  
 
 
4.4. CHARACTERIZATION OF IDENTIFIED 
MUTATIONS 
 
A total of 13 SNPs were identified in ND1 and ND2. Four of these SNPs 
have previously been characterized (A3480G, C3594T, G4580A, 
T4216C) (Howell et al., 1993; 1996; 1998; Chen et al., 1995; Thomas et 
al., 1996; Torroni et al., 1996; Macaulay et al., 1999; Rose et al., 2001; 
Finnilắ, 2001; Harrenstadt et al., 2002; Wong et al., 2004; Harris et al., 
2006). 
 
 The A3480G transition was characterized by Howell et al. (1993; 1996), 
Thomas et al. (1996) and Harris et al. (2006). In the present study, 7.5% 
of subfertile patients contained this mutation while 2.5% of fertile men 
had this mutation. Harris et al. (2006) found 8% of subfertile men 
contained this mutation, while for subfertile men it was only 1.4%. 
Thomas et al. (1996) studied 124 non-insulin dependent diabetes mellitus 
patients. He observed a population frequency of 1.22% with only one 
patient and with one control patient with this SNP. From all these studies 
it can be suggested that the subfertile population tend to show this SNP 
more than the normal fertile population.  
 
A mutation at nt 4216 was characterized in different studies as a 
secondary mutation associated with LHON (Leber’s hereditary optical 
neuropathy) (Howell et al., 1995; 1998; Rose et al., 2001; Harrenstadt et 
al., 2002; Wong et al., 2004; also in the published polymorphism data 
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obtained at www.mitomap.org as of 18th  may, 2006). Ruiz-Pesini et al. 
(2000) also utilized this polymorphic site as a marker to differentiate the 
T haplogroup which was present in 27% of Danes and Swedes 
population. Harrenstadt et al. (2002) showed that the occurrence of the 
highest number of polymorphism (46) in T haplogroup was at nt 4216. 
From this study it was found that 5% of subfertile men had the T4216C 
mutation. This percentage was just double what was found in normal 
men. Even though statistically it is not significant it has been established 
that this mutation was responsible for cause of LHON disease, so there 
might be a chance that this mutation may also affect human male fertility. 
 
The silent mutation C3594T was also characterized by Chen et al. (1995); 
Bandelt et al. (2002) and Harrenstadt et al. (2002). Harrenstadt et al. 
(2002) studied 56 African human gene sequences and found the presence 
of C3594T polymorphism in L1 and L2 haplogroups. The occurrences of 
this polymorphism in these haplogroups were 13 and 23, respectively, 
which was very common. The L haplogroup is defined for African origin 
populations (Torroni et al., 1996). Bandelt et al. (2002) and Chen et al. 
(1995) also observed this SNP in an African population. From the present 
study, only 2.5% normal men showed the presence of this mutation while 
no subfertile men had this SNP. The low rate of occurrence of this 
mutation suggested that this mutation might not be very common in the 
NZ Caucasian population. It is unlikely that it plays a role in causing poor 
semen parameters.  
 
Another silent mutant at nt 4580 in the ND2 gene was characterized by 
Torroni et al. (1996), Macaulay et al. (1999), Finnilắ et al. (2001) and 
Harrenstadt et al. (2002). The polymorphism at G4580A determines the 
haplogroup V, one of the European haplogroups (Finnilắ et al., 2001). 
44% of 192 Finnish Caucasian samples belonged to haplogroup V with 
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this mutation (Finnila et al., 2001).  Harrenstadt et al. (2002) stated that 
this mutant was previously established by Torroni et al. (1996) and 
Macaulay et al. (1999). These two studies were also done on European 
and Eurasian Caucasian populations. In the present study, 6.5% of fertile 
men and 4.3% of subfertile men contained this mutant. Therefore, this 
mutant might be common to NZ Caucasians but not significant to 
produce poor semen quality. 
 
 
4.5. CHARACTERIZATION OF SYNONYMOUS 
CODON USAGE 
 
Synonymous or silent mutations have traditionally been considered 
neutral as the sequence of the corresponding protein is unchanged and 
there is no phenotypic difference (Novella et al., 2004), However, 
recently studies have shown that not every synonymous site is neutral 
(Chamary et al., 2005; Duret, 2002). Codon usage reflects a balance 
between selective and neutral evolutionary forces (Bulmer, 1991; Semon 
et al. 2006). Novella et al. (2004) proposed that protein expression, 
control, splicing, temperature stability, tRNA availability and resistance 
to tRNA interference provide increasing evidence of differences in the 
selective value of a particular codon. So far, most of the experimental 
studies have been done with synonymous mutants of nuclear genes. The 
mitochondrial and nuclear genomes employ similar mechanisms of 
translation, however their origin and genetic code, are not identical. 
According to the, MITOMAP data (www.mitomap.org) a high percentage 
of synonymous substitutions in coding region have been associated with 
diseases. For example, in ND1, 49 (60%) of the SNPs are synonymous 
and 21 (42%) are associated with disease include LHON, MELAS, breast 
cancer, type 2 diabetes, etc. 
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Synonymous mutations in the mtDNA genome are more common in 
subfertile men than in fertile men (Ruiz-Pesini et al., 2000; Thangaraj et 
al., 2003; Harris et al., 2006). Gomas (2002) found 8% of subfertile men 
had the A3480G mutation in the ND1 gene. Similarly, from this study, 
7.5% of subfertile men have this mutation. Their codon was changed in 
the third position from AAA to AAG with a reduced relative codon usage 
frequency (1.71 to 0.29). However, a few other mutations found in this 
study also showed a change from a lower relative codon usage to a high 
relative codon usage (eg. G4580A, 0.17 to 1.83). Synonymous mutations 
(C7024T in COXI and C7891T in COXII) which were identified as T 
polymorphic site were also found in COX gene in men with reduced 
sperm mobility (Ruiz-Pesini et al., 2000).  
 
The synonymous mutations found by Harris et al. (2006) also showed 
58% (28 out of 48) of subfertile men showed reduced relative codon 
usage and only 33% (16 out of 48) with higher relative codon usage 
(Table 4.1). Four synonymous mutations out of 48 did not show any 
change in their relative codon usage (Table 4.1).  Similarly, from this 
study, more synonymous mutations in subfertile groups were associated 
with reduced relative codon usage (Table 4.2). All these studies suggest 
that synonymous codons with low frequency rate are more frequent in 
subfertile men.  
 
4.6. EFFECT OF IDENTIFIED MUTATIONS ON 
HUMAN MALE INFERTILITY  
 
Mutations in mtDNA have been found to be associated with a large 
number of diseases in humans. More than 100 different point mutations 
have been related to different diseases (Wallace, 1999; Thangaraj et al., 
2003). It has been suggested that abnormal mitochondrial function might 
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cause male infertility. Mitochondrial DNA mutations were found to be 
responsible for sperm dysfunction (Spiropoulos et al., 2002). Mutations 
in mtDNA genome could alter the performance of ATP production in 
spermatozoa, which can lead to a decline of motility of sperm (Ruiz-
Pesini et al., 2000). Reduced fertility may be associated with deletions of 
a few thousand base pairs of nucleotides in the sperm mitochondrial 
genome (Kao et al., 1998).  
 
Generally, if a mutation was solely responsible for a disease, it should be 
found in the patient with the disease, it should also be heteroplasmic and 
be able to affect the function of polypeptide in which the change occurs 
(Riordan-Eva et al., 1995). None of the mutations from this study 
fulfilled the above rules. As some mutations were present in normal and 
subfertile men, these mutations indicate that they might not be associated 
with male infertility. Most of the mutations were neutral. Only two 
mutations (T4216C and C3992T) change the amino acid in the 
polypeptide sequence. But their hydrophobicity plot, polarity value and 
predicted secondary structure suggested that there was no affect in the 
function of the protein product. These identified SNPs did not directly 
affect the function of ND1 and ND2 protein but the mutant codon might 
have an effect on protein translation efficiency machinery (Holyoake et 
al., 2001). If the tRNA showed a codon preference then it might lead to a 
change in the levels of protein production, leading to a loss of efficiency 
in energy production (Holyoake et al., 2001). When mutations have an 
effect on translation efficiency, then they would be responsible for sperm 
dysfunction.  
 
All the mutants in this study were homoplasmic. It is not known whether 
these mutations were transmitted maternally.  
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In the present study, statistical analysis showed that the Z values of all the 
mutations found in this study was less than the 5% value (z=1.96 at 5% 
level of significance). For example, the Z values in different mutations 
were: nt 3480 (z= 0.2236), nt 4216 (z= 0.129), nt 4580 (z= 0.932) and nt 
4514 (z=0.1203). Therefore the observed differences in all the four cases 
are not significantly different between fertile and subfertile men. 
 
However, it is evident that in some cases there might be an association 
between mitochondrial mutations and male infertility. But this study 
could only be stated that more mutations were found in subfertile men 
than in fertile men. In this study, the sample size was small and the study 
was only focused on the NZ Caucasian population. Based on a small 
study, it is difficult to establish the effect of mitochondrial mutations in 
male infertility.   
 
 
4.7. COMPARISON WITH PREVIOUS RESEARCH  
 
Eighty normozoospermic and 124 non-normozoospermic sample were 
analyzed by Harris et al. (2006) for nucleotide substitutions in 
mitochondrial genes by PCR and DNA sequencing. The entire region of 
the mtDNA genome except the cytochrome C and the D loop was 
analyzed. Several synonymous and non-synonymous mutants were found 
in different region of the mitochondrial genome. Sixty synonymous 
mutants of different fertility groups from the study of Harris et al. (2006) 
were compared with the human mitochondrial genetic codes and their 
frequencies of codon usage for each mitochondrial gene were determined 
(Table 3.3). The number of relative codon usage for each codon usage is 
tabulated in Table 4.1. Among the subfertile men, 28 of the 48 codon 
changes were from a high relative usage value to a low usage value. 
 
                                                                                      73
   
Among the normozoospermic samples, 6 of the 12 codon changes were 
from a low to a high relative codon usage and 5 of the 12 change from 
high to a low value. More silent mutants were change from a high to a 
low relative codon usage value. Similarly, synonymous mutants from this 
study showed more mutations that change to a low relative codon usage 
value (Table 4.2). 
 
Table 4.1. Number of mutations (silent) with reduced and higher 
codon usage rate against different fertility groups (Harris et al. 2006).        
 
 
Codon frequency change rate Classification of 
Mutants 
Total 
number 
of 
mutants 
     
Higher 
     
Lower 
No 
change 
Normozoospermic 12         6        5      1 
Asthenozoospermic 
Oligozoospermic 
Oligoasthenozoospermic
Severely 
Oligozoospermic  
Severely 
Oligoasthenozoospermic
Azoospermic  
 
12 
15 
  2 
 
  1 
 
10 
  8 
        4 
        4 
        1 
 
         - 
        
        5 
        2 
       5 
     11 
       1    
 
       1 
        
       4 
       6 
     3  
     - 
     - 
 
     -  
      
     1 
     - 
Total number of non-
normozoospermic  
48        16       28     4 
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Six out of ten synonymous mutations (60%) in subfertile groups showed 
reduced relative codon usage value while, four out of ten synonymous 
mutations (40%) were with higher relative codon usage value (Table 4.2).  
 
A total of 48 synonymous mutations were found in subfertile groups by 
Harris et al. (2006). For the calculation of Chi-square (χ2) value between 
the lower and higher relative codon usage, a total number of non-
normozoospermic synonymous mutations were 44, as 4 synonymous 
mutations did not show any change in their codon usage. All together 
including the results from Harris et al. (2006), a total of 34 (28+6) 
synonymous mutations out of 54 (44+10) subfertile samples (62%) 
showed a change to a lower relative codon usage value. Similarly, a total 
of 20 (16+4) synonymous mutations out of 54 (44+10) subfertile samples 
(37%) showed a change to higher relative codon usage values. Chi-square 
(χ2) value (χ2=0.067 with 1 d.f.; critical value = 3.841) shows that there is 
no significant difference at 5% level of significance between the lower 
and higher codon usage value of these synonymous mutations. These 
high frequencies of the synonymous mutations found in a population 
might be the result of a lack of selective pressure on the alleles. Although 
these mutations may provide a genetic background that renders the 
population more susceptible to influence by other mutations.   
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Table: 4.2. Mutations (silent) in ND1 and ND2 gene with reduced and 
higher codon usage rate against different fertility groups. 
 
             Codon frequency change rate Classification of Mutants Mutants 
     Higher      Lower No change 
Normozoospermic T3396C 
T3594C 
G3666A 
G3693A 
A3480G* 
G4580A* 
A4514G* 
 
       - 
       - 
       - 
       + 
       - 
       + 
       - 
         
       + 
       + 
       + 
       - 
       + 
       - 
       + 
    - 
    - 
    - 
    - 
    - 
    - 
    - 
Asthenozoospermic 
 
 
Oligozoospermic 
 
 
 
Oligoasthenozoospermic 
 
Severely Oligozoospermic  
A3480G* 
A4514G* 
 
G3591A 
A3480G* 
G4580A* 
C3567T 
C3450T 
G4580A* 
A4024G 
G4580A* 
       - 
       - 
 
       + 
       - 
       + 
       - 
       - 
       + 
       - 
       + 
       + 
       + 
 
        - 
       + 
        - 
       + 
       + 
       - 
       + 
       - 
    - 
    - 
      
    - 
    - 
    - 
    - 
    - 
    - 
    - 
    - 
* indicates that these mutants were found more than once in different fertility 
groups. To determine the Chi-square (χ2) value, these mutants in subfertile 
groups were considered as different mutations. 
 
Seven non-synonymous mutants from the research of Harris et al. (2006) 
were also analyzed. Their hydrophobic plot, polarity value and amino 
acid change were determined (Table 4.3). Change of amino acids due to 
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non-silent mutants suggested that codon usage was not relevant to semen 
quality in men.  
Table: 4.3. Hydrophathicity and Polarity analysis of non-silent 
mutants. 
 
Hydropathicity Polarity Clas
sific
atio
n 
Gene Sample Mutation Codon 
change 
Amino 
acid 
change 
Norma
l 
variant Norm
al 
varia
nt 
 
As 
 
ND2 
 
 
Am433B 
 
T5278C 
 
TTC?TCC 
 
Phe?Ser 
 
-0.756 
 
-1.156 
 
9.256 
 
9.700 
Az 
As 
ND6    4449 
AT665c 
6169 
C14213T ACC?AAT 
 
Thr?Asn 
 
1.833 1.489 6.600 6.889 
OAs 
As 
ND6     4850 
5004 
5360 
3099 
5310 
C14167T CTC?TTC Leu?Phe 1.600 1.411 7.167 7.167 
As 
OAs 
ND6     RL506B 
5585 
T14182C TAC?CAC Tyr?His 2.322 1.467 6.756 7.333 
O 
 
SOA
s 
N 
ND4 5378 
JN 
TM 
2905 
 
 
C11724T 
 
ACA?ATA 
 
Tre?Met 
 
0.811 1.100 7.689 7.367 
O ND5 5378 T14115A TTC?TAC Phe?Tyr 2.433 1.978 5.856 5.967    
O ND5 2565 T13740C CTA?CCA Leu?Pro 1.489 0.889 7.444 7.789 
 
Here, As= Asthenozoospermic, Az= Azoospermic, OAs= 
Oligoasthenozoospermic, SOAs= Severely oligozoospermic, O= 
Oligozoospermic and N= Normozoospermic samples. 
 
Most of the non-synonymous mutants were hydrophobic (Kyte and 
Dolittle, 1982) and nonpolar. One mutation in the ND2 protein had a 
changed amino acid from phenylalanine, a nonpolar hydrophilic amino 
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acid to serine, a polar negatively charged amino acid. This mutant might 
have an affect on the ND2 polypeptide. The secondary structure of this 
mutant protein is also varied, which gave an idea that there was a change 
in ND2 polypeptide (Gomas, 2002).  
 
4.8. FUTURE DIRECTIONS 
Mutations were detected in the ND1 and ND2 of the mitochondrial 
genome by automated DNA sequencing. Most of the previous studies 
used SSCP analysis for preliminary mutation screening. The suspected 
mutations were confirmed by DNA sequencing. However, positives and 
negatives were detected frequently. In the present study, PCR 
amplification of the genes of interest and DNA sequencing was employed 
throughout. In order to determine the relevance of various mutations the 
mitochondrial genome in relation to semen quality, biochemical analyses 
must be carried out to establish the stability of these mutant proteins and 
to determine the function of ND1 and ND2 polypeptides. Detailed 
analysis of possible influence of different codons on translation efficiency 
should be performed.   
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4.9. CONCLUSIONS 
This study has identified 13 SNPs in the ND1 and ND2 genes. Eleven of 
these were synonymous and two were non-synonymous. Four of them 
were previously characterized and all of them were homoplasmic. None 
of the identified SNPs are likely to affect the function of polypeptides on 
the basis of the hydrophobicity plots or secondary structure predictions. 
More mutations were synonymous. A higher frequency of SNPs in ND1 
and ND2 were found in subfertile men then in fertile men, a trend 
consistent with previous studies of other mitochondrial genes. Combined 
results obtained from Harris et al. (2006) and the present study showed 
that more synonymous mutations (62%) in subferile groups changed their 
codon usage value from a high to a low relative codon usage which was 
not significantly different (χ2= 0.067 with 1 d.f.) at 5 % level of 
significance. However, there were some mutations (37%) in subfertile 
samples that changed the relative codon usage value from low to high. 
Thus, change in codon usage was not related to semen quality in men. 
Statistical analysis also revealed insignificant differences in observed 
differences in the frequencies of SNPs of fertile and subfertile men. 
However, this small study included only a NZ Caucasian population; an 
extended population survey may provide insights into the role of SNPs in 
relation to male infertility.  
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APPENDIX 1: ABBREVIATIONS 
  
 
A Adenine or adenosine; 
alanine 
nt Nucleotide 
A260 Absorbance at 260 nm Nacl Sodium chloride 
A280 Absorbance at 280 nm PCR Polymerase chain reaction 
ATP Adenosine 5/ triphosphate s seconds 
bp Base pair SDS Sodium dodecyl sulfate 
C Cytosine or cytidine; 
cystine 
ss Single stranded 
dATP Deoxyadenosine 
triphosohate 
T Thymine or thymidine; 
threonine 
dCTP  Deoxycytidine 
triphosphate 
Taq Thermus aquaticus DNA 
dGTP  Deoxyguanosine 
triphosphate 
TBE Tris borate electrophoresis 
buffer 
dNTP  Deoxyribonucleotiside 
triphosphate 
TEMED Tetramethylethyldiamine 
dTTP  Deoxythymidine 
triphosphate 
Tm Melting temperature 
ddH2O Deionized distilled water Tris Tris (hydroxymethyl) 
aminomethane 
DNA Deoxyribonucleotide U unit 
ds  Double stranded UV Ultraviolet 
DTT  Dithiothreiotol V Volt 
EDTA Ethylenediaminetetra 
acetic acid 
W Watts 
G Guanine or guanosine; 
glycine 
g Grams 
h  Hours l Liters 
kDa Kilo Dalton m meters 
M Molar   
mA Milliamps   
min Minutes   
MgCl2 
 
Magnesium chloride 
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APPENDIX 2: CHEMICAL SUPPLIERS 
 
 
PRODUCT SUPPLIER PRODUCT SUPPLIER 
Agarose Invitrogen SDS Invitrogen 
Ammonium acetate BDH Sodium 
carbonate 
Scharlau 
(Scientific 
Supplies ltd.) 
Big DyeTM termination V 3.1 
cycle sequencing kit 
Applied Bio 
System 
Sodium 
hydroxide 
Scharlau 
(Scientific 
Supplies ltd.) 
Chloroform BDH Sodium 
cloride 
Scharlau 
(Scientific 
Supplies ltd.) 
Deoxynucleotidetriphosphates Eppendrof TEMED Sigma 
Ethanol BDH Tris base Roche 
Ehilium Bromide Sigma Taq 
Plymerase 
Roche 
EDTA Scharlau 
(Scientific 
Supplies ltd.) 
  
Formaldehyde BDH   
Gel band purification kit Amersham 
Biosciences 
  
Isoamyl alcohol BDH   
Isopropanol BDH   
Magnesium acetate BDH   
Orange G Sigma   
Phenol Scharlau 
(Scientific 
Supplies ltd.) 
  
Proteinase K Roche   
Sodium acetate BDH   
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APPENDIX 3: SEMEN SAMPLES 
 
 
 
Normozoospermic group: 
 
Used for PCR and Sequencing         Sample Sperm count 
(M/ml) 
Motility 
     % 
ND1 ND2 
1751 76 54 + + 
1929 63 77 + + 
2151 43 72 + + 
2169 55 55 + + 
2223 57 56 + + 
2430 265 52 + + 
2446 87 67 + + 
2450 113 70 + + 
2521 108 72 + + 
2551 70 55 - - 
2595 96 53 - - 
2619 61 54 - - 
2407 95 54 + + 
2752 109 61 + + 
2945 110 61 - - 
3999 348 66 + + 
4038 56 53 - - 
4510 51.3 74 + + 
4937 112 67 + + 
5697 69 70 + + 
5390 131 67 + + 
5769 64 78 - - 
6570 77 68 + + 
6635 99 80 + + 
6732 89 65 - - 
4948 104 77 - - 
6357 58 72 + + 
6661 66 71 - - 
6682 26 88 + + 
6750 75 79 + + 
7028 141 61 + + 
3945 57 79 + + 
5250 30 56 - - 
7009 105 52 + + 
6619 109 74 + + 
AM 257b 55 66 + + 
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Used for PCR and Sequencing 
      
 
   Sample 
 
 
Sperm count 
(M/ml) 
 
 
Motility 
     % ND1 ND2 
QD201B 67 60 + + 
QN222J 44 72 - - 
SF 94-97 86 72 + + 
SF 96-220 67 47 - + 
SF 96-229 75 50 + + 
SF 95-79 107 53 - + 
SF 148 27 52 + - 
010136 67 71 + + 
009807 61 67 - - 
009810 74 57 + + 
010381 138 60 - - 
010294 313 60 - - 
010004 60 66 - + 
010641 72 67 - + 
009820 150 58 - - 
010526 109 63.6 + + 
009940 96 49 - - 
010772 108 62 - - 
010707 56.5 55 - + 
010797 62 57 - - 
010830 98 37 - - 
010745 127 89 + + 
010286 141 57 + + 
010558 111 229 + + 
009949 66 62 + + 
019249 79 83 + + 
009912 110 19 - - 
010032 110 31 - - 
009950 133 50 - - 
010495 98 64 + + 
010525 49 23 - - 
010557 140 66 - - 
010388 109 53 - - 
010653 79 66 - - 
2660 55 70 - - 
010573 93 62 + + 
010081 109 53 + + 
6383 70 56 + + 
AT 635c 148 80 - - 
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Asthenozoospermic group: 
 
 
Used for PCR and sequencing         Sample Sperm 
count 
(M/ml) 
Motility 
     % 
ND1 ND2 
1874 46 27 + + 
2409 55 28 + + 
2651 36 37 + + 
2655 52 41 - - 
2660 72 26 + + 
2675 32 32 + + 
2758 67 38 - - 
2806 42 48 - - 
2902 32 35 + + 
3312 74 42 - - 
4932 176 35 + + 
5453 65 33 - - 
5937 34 74 - - 
5097 65 37 + + 
4170 27 28 + + 
6740 81 40 - - 
5535 65 33 + + 
6112 21 38 + + 
94-149 34 40 - - 
RS 36 23 + + 
SF 94-104 21 74 - - 
2261 71 23 + + 
0109393 23 56 + + 
009884 17 71 + + 
010449 49 23 + + 
010749 71 46 + + 
010324 54 27 + + 
010140 33 41 - - 
010471 21 44 - - 
009831 32 40 - - 
010447 21 43 + + 
010703 524 27 + + 
010620 30 40 + + 
010480 70 24 + + 
010749 71 46 - - 
010036 36 60 - - 
010525 45 36 + + 
010545 74 19 + + 
010439 44 39 - - 
010703 72 32 + + 
010527 71 46 + + 
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010756 21 44 + + 
2495 24 31 + + 
 
 
Oligozoospermic group: 
 
 
Used for PCR and sequencing         Sample Sperm 
count 
(M/ml) 
Motility 
     % 
ND1 ND2 
2703 13.4 42 - - 
6768 3.8 38 + + 
2902 3.2 32 + + 
1699 10.70 67 - - 
6994 14 57 - + 
SF 94-99 4 50 - - 
010830 4.6 15 + + 
3535 11 51 + + 
QR497E 15 57 - - 
010208 4.6 22 + + 
 
 
Oligoasthenozoospermic group: 
 
 
Used for PCR and sequencing         Sample Sperm count 
(M/ml) 
Motility 
     % 
ND1 ND2 
5292 15.5 26 - - 
5593 13 18 - - 
6471 6.7 47 - - 
6445 9.3 39 + + 
5916 9.3 39 - - 
AT 665c 17 26 - + 
AM470T 10.6 15 - - 
020527 5.4 23 - + 
010406 8.9 60 + + 
1754 15.1 4 - - 
009593 21 50 + + 
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Severely Oligozoospermic group: 
 
 
Used for PCR and sequencing         Sample Sperm count 
(M/ml) 
Motility 
     % 
ND1 ND2 
010596 4.6 70 + + 
5293 1.41 52 - - 
6344 3 72 - - 
010716 0.7 34 - - 
009884 0.7 51 - + 
010639 1 4 + + 
 
 
 
Severely Oligoasthenozoospermic group: 
 
 
Used for PCR and sequencing     Sample Sperm count 
(M/ml) 
Motility 
     % 
ND1 ND2 
010583 3 1 - - 
5080 1 8 - + 
6745 3.8 8 + + 
2598 2.3 8 - - 
010494 3.2 5 - - 
 
 
Azoospermic group: 
 
 
Used for PCR and sequencing Sample Sperm count 
(M/ml) 
Motility 
     % 
ND1 ND2 
2762 0 0 - + 
010729 0 0 + + 
4071 0 0 - - 
 
Samples with identified mutations are shown in bold format. 
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APPENDIX 4 
MITOMAP: Reported Mitochondrial DNA Base Substitution 
Diseases:  
Coding and Control Region Point Mutation 
Last edited May 18, 2006 
 
Loc
us 
Disease Allele Nucleoti
de 
Position 
Nucldoti
de 
Change 
Amin
o 
Acid 
Chan
ge 
Hom
o- 
plas
my 
Hete
ro- 
plas
my 
MT-
ND1 
 MELAS T3308
C 
3308 T-C M-T - + 
MT-
ND1  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
NIDDM; 
LHON; PEO
G3316
A 
3316 G-A A-T + - 
MT-
ND1
LHON/MEL
AS overlap
G3376
A 
3376 G-A E-K + + 
MT-
ND1
LHON; 
NIDDM; 
CPT 
deficiency
T3394
C 
3394 T-C Y-H + - 
MT-
ND1
ADPD A3397
G 
3397 A-G M-V + - 
MT-
ND1
LHON G3460
A 
3460 G-A A-T + + 
MT-
ND1
LHON G3496
T 
3496 G-T A-S + - 
MT-
ND1
LHON C3497
T 
3497 C-T A-V + - 
MT-
ND1
LHON G3635
A 
3635 G-A S-N + - 
MT-
ND1
MELAS G3697
A 
3697 G-A G-S - + 
MT-
ND1
LHON G3700
A 
3700 G-A A-T + - 
MT-
ND1
LHON G3733
A 
3733 G-A E-K + + 
MT-
ND1
Adult-Onset 
Dystonia
A3796
G 
3796 A-G T-A - + 
MT-
ND1
MELAS G3946
A 
3946 G-A E-K + + 
MT-
ND1
MELAS T3949
C 
3949 T-C Y-H - + 
MT-
ND1
LHON A4136
G 
4136 A-G Y-C + - 
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MT-
ND1 
 LHON T4160
C 
4160 T-C L-P + - 
MT-
ND1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
  
  
 
 
  
  
  
  
  
  
  
  
LHON C4171
A 
4171 C-A L-M + + 
MT-
ND1
LHON T4216
C 
4216 T-C Y-H + - 
MT-
ND2
LHON C4640
A 
4640 C-A I-M + - 
MT-
ND2
LHON A4917
G 
4917 A-G N-D + - 
MT-
ND2
Longevity C5178
A 
5178 C-A L-M + - 
MT-
ND2
LHON G5244
A 
5244 G-A G-S - + 
MT-
ND2
AD; PD G5460
A 
5460 G-A A-T + + 
MT-
ND2
AD G5460
T 
5460 G-T A-S + + 
MT-
CO1
Prostate 
Cancer
C5911
T 
5911 C-T A-V + - 
MT-
CO1
Prostate 
Cancer
G5913
A 
5913 G-A D-N + - 
MT-
CO1
Myoglobinur
ia; Exercise 
Intolerance
G5920
A 
5920 G-A W-
Ter 
- + 
MT-
CO1
Prostate 
Cancer
A5935
G 
5935 A-G N-S + - 
MT-
CO1
Prostate 
Cancer
G5973
A 
5973 G-A A-T + - 
MT-
CO1
Motor 
Neuron 
Disease
6020de
l5 
6020 5bp 
deletion- 
ACL
GG-
AGP
ATer 
- + 
MT-
CO1
Prostate 
Cancer
G6081
A 
6081 G-A A-T + - 
MT-
CO1
Prostate 
Cancer
G6150
A 
6150 G-A V-I + - 
MT-
CO1
Prostate 
Cancer
T6253
C 
6253 T-C M-T + - 
MT-
CO1
Prostate 
Cancer
G6261
A 
6261 G-A A-T + - 
MT-
CO1
Prostate 
Cancer
G6267
A 
6267 G-A A-T + - 
MT-
CO1
Prostate 
Cancer
G6285
A 
6285 G-A V-I + - 
MT-
CO1
Prostate 
Cancer
C6340
T 
6340 C-T T-I + - 
MT-
CO1
Prostate 
Cancer
G6480
A 
6480 G-A V-I + - 
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MT-
CO1 
 
Therapy-
resistant 
Epilepsy
C6489
A 
6489 C-A L-I - + 
MT-
CO1  
 
 
 
 
 
 
  
  
  
  
  
  
Prostate 
Cancer
A6663
G 
6663 A-G I-V + - 
MT-
CO1
MM & 
Rhabdomyol
ysis
G6708
A 
6708 G-A G-Ter - + 
MT-
CO1
Acquired 
Idiopathic 
Sideroblastic 
Anemia
T6721
C 
6721 T-C M-T - + 
MT-
CO1
Acquired 
Idiopathic 
Sideroblastic 
Anemia
T6742
C 
6742 T-C I-T - + 
MT-
CO1
Multisystem 
Disorder
G6930
A 
6930 G-A G-Ter - + 
MT-
CO1
Prostate 
Cancer
G7041
A 
7041 G-A V-I + - 
MT-
CO1
Prostate 
Cancer
T7080
C 
7080 T-C F-L + - 
MT-
CO1
Prostate 
Cancer
A7083
G 
7083 A-G I-V + - 
MT-
CO1
Prostate 
Cancer
A7158
G 
7158 A-G I-V + - 
MT-
CO1
Prostate 
Cancer
A7305
C 
7305 A-C M-L + - 
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APPENDIX 5: ND1 AND ND2 GENES 
 
 
ND1 Gene sequence and Primer Binding sites 
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ND2 Gene sequence and Primer Binding sites 
 
 
 
 
 
 
 
